Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.4096095338662667e-26,11.914133683213063,702.7879118005609,"['RPL4', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.42648884404883e-23,0,0,70
2,"GPCRs, Class A Rhodopsin-like WP455",1.4997127366683245e-11,3.370836202986679,84.01189825259449,"['NPFFR2', 'GPR27', 'CHRM2', 'OXTR', 'NPFFR1', 'CHRM1', 'GPR68', 'GPR22', 'CHRM5', 'NPY2R', 'HTR2B', 'GPR20', 'ADRA1D', 'ADRA1B', 'ADRA1A', 'MC4R', 'EDNRA', 'EDNRB', 'HTR7', 'GPER1', 'GPR171', 'PTGDR', 'GPR39', 'LHCGR', 'GPR34', 'OR2H2', 'F2R', 'SSTR1', 'ADRA2C', 'SSTR3', 'TRHR', 'CCKBR', 'ADORA2A', 'FSHR', 'APLNR', 'OR3A2', 'GPR87', 'PTGER3', 'OPRL1', 'FPR3', 'GPR83', 'ADRB1', 'MCHR1', 'HRH1', 'P2RY6', 'RHO', 'DRD3', 'NTSR1', 'DRD5', 'P2RY12', 'P2RY13', 'GPR12', 'HTR1E', 'P2RY14', 'HTR1D', 'GPR52', 'GPR3', 'GPR6', 'HTR5A', 'HCRTR2', 'HCRTR1', 'MAS1', 'OPN1SW', 'LPAR6', 'ACKR4', 'NMUR2', 'ACKR2', 'RGL4', 'GPR18']",4.4391497005382405e-09,0,0,69
3,Electron Transport Chain (OXPHOS system in mitochondria) WP111,8.216387185437298e-10,3.7815562333701083,79.10909882425825,"['COX7B', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'UCP1', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ']",1.6213670712596268e-07,0,0,50
4,"GPCRs, Other WP117",7.545046756214503e-06,3.2874688630702376,38.77444359789437,"['CHRM2', 'GPR88', 'OR2M4', 'ADRA1D', 'GPR83', 'CELSR2', 'RXFP1', 'ADGRE2', 'EDNRA', 'GPR132', 'PROKR2', 'HTR7', 'ADGRE3', 'HRH4', 'GNRHR', 'DRD3', 'NTSR1', 'GPR135', 'P2RY13', 'ADGRV1', 'F2R', 'GPR55', 'GPR162', 'CCKBR', 'ADORA2A', 'FSHR', 'GPR183', 'OR10A2', 'ACKR1', 'LGR6', 'GPR18']",0.0011166669199197464,0,0,31
5,Oxidative phosphorylation WP623,1.0544211215030145e-05,3.484360836505956,39.93054364580805,"['NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP6AP1', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5']",0.0012484346078595692,0,0,28
6,Complement and Coagulation Cascades WP558,5.1624573563897656e-05,3.432099975496202,33.880018725664826,"['C1QB', 'C1QA', 'CPB2', 'CFH', 'SERPIND1', 'F10', 'F12', 'SERPINE1', 'SERPINF2', 'F2R', 'C5AR1', 'PLAT', 'PLG', 'TFPI', 'CLU', 'F5', 'C2', 'C3', 'THBD', 'C6', 'C9', 'MASP2', 'KLKB1', 'C1QC']",0.0050936245916379025,0,0,24
7,Mitochondrial CIV Assembly WP4922,6.644481552620858e-05,4.177510448435559,40.184052827426065,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'SCO2', 'COX14']",0.005619332970216497,0,0,19
8,Computational Model of Aerobic Glycolysis WP4629,0.0001736210935152984,12.843017578125,111.20300480430423,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'SLC2A1', 'ENO1', 'ALDOA', 'GAPDH', 'PFKM']",0.012847960920132082,0,0,9
9,Nonalcoholic fatty liver disease WP4396,0.0002459528425201227,1.91080391672838,15.879488954643255,"['NDUFA13', 'COX7B', 'GSK3A', 'NDUFA11', 'COX4I1', 'COX6A1', 'COX7C', 'CASP7', 'CASP8', 'LEPR', 'MLX', 'UQCRFS1', 'RAC1', 'NDUFC2', 'NDUFC1', 'COX6B1', 'TNFRSF1A', 'NDUFS6', 'DDIT3', 'NDUFS5', 'ATF4', 'CEBPA', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFA8', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'COX6C', 'UQCRHL', 'UQCRQ', 'LEP', 'CYCS', 'BAX']",0.015400787183040592,0,0,54
10,Monoamine GPCRs WP58,0.00026014843214595593,4.15518353009182,34.29795771320433,"['CHRM2', 'CHRM1', 'HTR1E', 'CHRM5', 'HTR1D', 'HTR2B', 'ADRB1', 'ADRA1D', 'ADRA1B', 'HTR5A', 'ADRA2C', 'ADRA1A', 'HRH1', 'HTR7', 'DRD3', 'DRD5']",0.015400787183040592,0,0,16
11,Peptide GPCRs WP24,0.0003582936152766813,2.994553491247099,23.759259800256576,"['OXTR', 'LHCGR', 'NPY2R', 'C5AR1', 'TACR2', 'OPRL1', 'FPR3', 'SSTR1', 'SSTR3', 'TSHR', 'HCRTR2', 'TRHR', 'HCRTR1', 'MC4R', 'EDNRA', 'EDNRB', 'CCKBR', 'FSHR', 'GNRHR', 'TAC4', 'ACKR1', 'NTSR1']",0.01928271093125412,0,0,22
12,Glycolysis and Gluconeogenesis WP534,0.0004073586340582373,3.1753025975792193,24.785829712734767,"['TPI1', 'GOT1', 'MDH2', 'PGAM1', 'SLC2A1', 'SLC2A3', 'ENO1', 'ENO2', 'GCK', 'LDHC', 'LDHA', 'PKM', 'MPC2', 'PGK1', 'ALDOC', 'ALDOB', 'ALDOA', 'FBP1', 'PFKM', 'GAPDH']",0.020096359280206377,0,0,20
13,Spinal Cord Injury WP2431,0.00044466491973684067,2.0819859107681986,16.069161897223985,"['C1QB', 'BTG2', 'CDKN1B', 'XYLT1', 'AIF1', 'NTN1', 'RTN4', 'EGFR', 'TNFSF13B', 'LGALS3', 'ACAN', 'PRB1', 'MYC', 'E2F1', 'SLIT3', 'NOS1', 'RAC1', 'ROS1', 'MAPK3', 'EGR1', 'TGFB1', 'GADD45A', 'ARG1', 'MIF', 'PDYN', 'LILRB3', 'GFAP', 'RHOB', 'SELP', 'FKBP1A', 'BCAN', 'NR4A1', 'VCAN', 'LEP', 'APEX1', 'CCNG1', 'CSPG4', 'LTB', 'VIM', 'TLR4']",0.020249356344939205,0,0,40
14,Selenium Micronutrient Network WP15,0.0008914202182559934,2.257797868905392,15.855824938533994,"['SERPINA3', 'SERPINE1', 'PLAT', 'PLG', 'TXN', 'SELENOK', 'SELENOH', 'PRDX3', 'PRDX5', 'RFK', 'PNPO', 'SEPHS2', 'GGT2', 'ABCA1', 'GPX2', 'GPX4', 'GPX3', 'DIO1', 'APOA1', 'KMO', 'SOD2', 'SOD1', 'SELENOM', 'SELENOS', 'ALB', 'SELENOW', 'SELENOV', 'SAA2', 'SELENOT', 'MSRB1']",0.037694340657682006,0,0,30
15,Blood Clotting Cascade WP272,0.0010988104599857428,5.707936507936508,38.89117999243656,"['F8A1', 'SERPINB2', 'F10', 'F12', 'SERPINE1', 'SERPINF2', 'PLG', 'PLAT', 'KLKB1', 'F5']",0.043366386154103986,0,0,10
16,Vitamin D Receptor Pathway WP2877,0.0012970781713803861,1.8289945525717883,12.158499367667396,"['COLEC11', 'CEBPA', 'STEAP4', 'ABCB1', 'CDKN1B', 'COL13A1', 'HILPDA', 'TNFRSF11B', 'CLDN2', 'ADRA1B', 'CYP3A4', 'CYP3A5', 'FOXO1', 'THBD', 'SULT1C2', 'ADAMTS5', 'BGLAP', 'MYC', 'DND1', 'CREG2', 'BTLA', 'TIMP2', 'TIMP3', 'SOSTDC1', 'LGALS9', 'JUNB', 'CDKN2D', 'CDKN2B', 'TGFB1', 'CDKN2C', 'IGFBP5', 'GADD45A', 'VDR', 'CDKN2A', 'IGFBP3', 'MX2', 'G0S2', 'CEACAM1', 'CYP24A1', 'TRPV6', 'TNFSF4', 'S100A6', 'PRKCQ', 'CLPTM1L', 'S100A9', 'S100A8']",0.04799189234107429,0,0,46
17,Allograft Rejection WP2328,0.0017521910217059673,2.4343096158382784,15.450291126246785,"['CD86', 'C1QB', 'C1QA', 'ABCB1', 'TGFB1', 'CD80', 'HLA-C', 'CXCL13', 'HLA-F', 'HLA-E', 'C2', 'VEGFA', 'C3', 'CASP7', 'CASP8', 'C6', 'IL5', 'GNLY', 'C9', 'HLA-DRA', 'VIM', 'MICA', 'C1QC']",0.061017475579407794,0,0,23
18,Proximal tubule transport WP4917,0.0030651517276782136,2.3996767874632714,13.888509054305255,"['ATP6V1A', 'SLC47A2', 'ATP6V1G1', 'ATP6V0B', 'SLC22A6', 'ABCC2', 'ABCB1', 'SLC2A1', 'SLC3A1', 'ATP1A1', 'ATP1B1', 'SLC5A2', 'SLC7A9', 'FXYD2', 'ATP6V0A4', 'ATP6V1E1', 'SLC22A8', 'ATP6V0C', 'ATP6V1D', 'ATP6V1B1', 'ATP6V1F']",0.09894288018433683,0,0,21
19,RAS and bradykinin pathways in COVID-19 WP4969,0.0031755316275378373,3.9241573033707864,22.57285243207132,"['ACE2', 'CYP24A1', 'VDR', 'F12', 'SERPINE1', 'REN', 'NOS1', 'CYP3A4', 'KLKB1', 'PRKG1', 'AGT']",0.09894288018433683,0,0,11
20,Complement system WP2806,0.003406378552984974,1.9944071907547438,11.33243218736986,"['FKBP2', 'SELPLG', 'CFH', 'C5AR1', 'C4BPA', 'ADM', 'PLG', 'TXN', 'THBS1', 'C2', 'C3', 'FCGR3A', 'GNA15', 'C6', 'RPS19', 'C9', 'C1QBP', 'CD59', 'VSIG4', 'PRNP', 'F10', 'F12', 'APOA1', 'SELE', 'SELP', 'SELL', 'ALB', 'MASP2', 'CALR', 'KLKB1']",0.10082880516835524,0,0,30
21,Drug Induction of Bile Acid Pathway WP2289,0.0036122022276163473,5.705638271906273,32.085301117069896,"['ABCC3', 'ABCB1', 'ABCC2', 'VDR', 'SLC10A1', 'SLC51A', 'CYP3A4', 'ABCB11']",0.10182970089280369,0,0,8
22,Exercise-induced Circadian Regulation WP410,0.004202544928985236,2.307183756498154,12.625059486481764,"['IDI1', 'DAZAP2', 'HSPA8', 'CEBPB', 'BTG1', 'RBPMS', 'GSTP1', 'NCOA4', 'G0S2', 'GFRA1', 'NR1D2', 'AZIN1', 'HERPUD1', 'PER2', 'DNAJA1', 'CLDN5', 'SUMO1', 'TUBB3', 'STBD1', 'SUMO3', 'EIF4G2']",0.11308666354360271,0,0,21
23,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.004554892793463899,inf,inf,"['ACE2', 'NRP1', 'FURIN', 'VEGFA']",0.11723897972741863,0,0,4
24,Differentiation Pathway WP2848,0.004856831691705805,2.5548588938098673,13.610675990917816,"['NOTCH1', 'TGFB1', 'HGF', 'PDGFB', 'FLT3LG', 'IGF1', 'FGF1', 'DKK1', 'VEGFA', 'NT5E', 'TPO', 'TF', 'FGF8', 'KIT', 'WNT2', 'NODAL', 'FGF10']",0.11980184839540987,0,0,17
25,Aryl Hydrocarbon Receptor Pathway WP2873,0.00547617913086174,2.8545587875824983,14.86468002313601,"['HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'SERPINB2', 'MYOF', 'AIP', 'EGFR', 'SLC7A5', 'CDC37', 'CYP1B1', 'BAX', 'HES1', 'JUNB']",0.12589728309945908,0,0,14
26,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.0055292725685573245,4.279541015625,22.243766120953165,"['CD63', 'CD81', 'HSPB1', 'IGF1', 'PDLIM5', 'TLR4', 'EGFR', 'ETS2', 'SOD1']",0.12589728309945908,0,0,9
27,Pyrimidine metabolism WP4022,0.0064722068662705825,1.8293346427694575,9.220282230850053,"['DPYS', 'PRIM1', 'TYMP', 'NT5C', 'POLD4', 'ZNRD1', 'POLR2C', 'POLD1', 'TWISTNB', 'POLD2', 'POLR2E', 'TK1', 'POLR2I', 'POLE', 'POLR2J', 'POLR2K', 'POLR2L', 'ENTPD1', 'RRM2', 'NME2', 'UPB1', 'NME1', 'POLE4', 'RRM2B', 'POLE2', 'POLR1C', 'POLE3', 'POLR1E', 'CMPK2', 'POLR3H', 'DCTPP1', 'POLR3K']",0.14190912832711797,0,0,32
28,Nuclear Receptors Meta-Pathway WP2882,0.006902205912052767,1.423741294563905,7.084414554748416,"['CDKN1B', 'SRXN1', 'SLC2A1', 'KEAP1', 'SLC2A3', 'GCC1', 'THBD', 'RGS2', 'CPT2', 'MYC', 'FTH1', 'ENC1', 'SLC39A6', 'CYP1B1', 'SLC39A7', 'JUNB', 'SLC39A1', 'SLC39A4', 'GGT2', 'SLC39A3', 'SRGN', 'ABCC3', 'HSP90AA1', 'GPX2', 'SERPINB2', 'ABCC2', 'GPX3', 'TSC22D3', 'HGF', 'SLC2A12', 'MYOF', 'SLC39A11', 'AIP', 'APOA1', 'NRG1', 'CES4A', 'SLC7A5', 'KAT2B', 'CYP2A6', 'SLC5A9', 'NAV3', 'CDC37', 'B3GNT5', 'ADGRF4', 'MFGE8', 'FKBP5', 'FTL', 'ABCB1', 'ABCB4', 'GSTP1', 'AMIGO2', 'PDGFB', 'SLC5A12', 'TXN', 'SLC5A2', 'ABCB11', 'CYP2C19', 'CYP3A4', 'SLC5A3', 'CYP3A5', 'EGFR', 'FOXO1', 'CYP3A7', 'DNAJB1', 'HMOX1', 'HES1', 'CBR3', 'EGR1', 'JUN', 'TGFB1', 'GADD45B', 'SLC10A1', 'VDR', 'PLK2', 'PSMC5', 'FASN', 'BHLHE40', 'MAFF', 'SPINK13', 'BAX', 'SPRY1']",0.14593235356911566,0,0,81
29,Development and heterogeneity of the ILC family WP3893,0.007259816532049292,4.564120087869172,22.480120373951078,"['IL5', 'NFIL3', 'IL15', 'IL7', 'ID2', 'IL18', 'RORA', 'TOX']",0.14820039265424764,0,0,8
30,Senescence and Autophagy in Cancer WP615,0.007718082999668764,1.779696593394373,8.656781059004151,"['CEBPB', 'CDKN1B', 'SERPINE1', 'PLAT', 'ING1', 'THBS1', 'GABARAP', 'MAP1LC3B', 'MAP1LC3A', 'LAMP1', 'E2F1', 'COL10A1', 'IGFBP7', 'SLC39A1', 'HRAS', 'SLC39A4', 'SLC39A3', 'GABARAPL2', 'GABARAPL1', 'JUN', 'TGFB1', 'SERPINB2', 'IGFBP5', 'CDKN2A', 'IGFBP3', 'FN1', 'HMGA1', 'IGF1', 'COL1A1', 'RSL1D1', 'BCL2', 'IL6ST', 'CD44']",0.15230350452679695,0,0,33
31,Pregnane X receptor pathway WP2876,0.008724459503496616,3.138788470933073,14.882957132802243,"['ABCC3', 'HSP90AA1', 'PSMC5', 'CYP2A6', 'ABCB1', 'ABCC2', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1', 'CYP3A7']",0.16660903309903216,0,0,11
32,Mitochondrial complex I assembly model OXPHOS system WP4324,0.00986151750196595,2.067977641933196,9.552226994982918,"['NDUFA8', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'TMEM186', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.1824380737863701,0,0,21
33,IL-18 signaling pathway WP4754,0.010512799027082813,1.421691732859085,6.476035885947794,"['BTG2', 'CD83', 'CD81', 'NCF2', 'HSPB8', 'HSPB1', 'ENO1', 'RND2', 'FAM110A', 'ADAMTS5', 'CASP8', 'ABHD16A', 'PPP1R13L', 'TMSB4X', 'FAM186B', 'STMN1', 'NPPA', 'TIMP3', 'IER3', 'TICAM2', 'USP5', 'IMP3', 'ARG1', 'PRKCD', 'IL18', 'NDUFC1', 'BPGM', 'KRT31', 'TNFRSF1A', 'ACTA2', 'CCNA2', 'ARL4D', 'ACTA1', 'CLDN4', 'LTB', 'ATF3', 'ARF6', 'MYH7', 'CEBPB', 'NRN1', 'STOML1', 'MEPCE', 'COX17', 'TNFRSF11B', 'ACACB', 'FUT1', 'CENPB', 'IRAK1', 'HMOX1', 'FADD', 'MAPK3', 'SLC12A3', 'JUN', 'BAD', 'FN1', 'EEF2', 'VEGFA', 'COL1A1', 'NFKBIA', 'NR4A1', 'TF', 'NACA', 'TNIP3', 'BCL2', 'CYCS', 'BAX', 'PTPN7', 'NFKBIE', 'CDK5R2', 'SNTB1', 'AARS', 'ITM2C']",0.1885932431525159,0,0,72
34,Myometrial relaxation and contraction pathways WP289,0.016099273351554734,1.509962288391359,6.234605813074753,"['RYR1', 'OXTR', 'RGS14', 'YWHAB', 'ATP2A2', 'ITPR3', 'ADM', 'RXFP1', 'RXFP2', 'ETS2', 'ACTB', 'RYR3', 'ACTG1', 'RGS4', 'CNN1', 'RGS2', 'GNG3', 'GRK5', 'RGS1', 'GNG8', 'IGFBP6', 'NOS1', 'RGS9', 'YWHAG', 'CORIN', 'YWHAH', 'JUN', 'IGFBP5', 'IGFBP3', 'IGFBP2', 'PRKCD', 'GNG12', 'GNG11', 'ACTA2', 'CREB3', 'ACTA1', 'ACTC1', 'PRKAR1A', 'MAFF', 'GNB4', 'CRH', 'PRKCQ', 'CALM3', 'CALM1', 'CALM2', 'ATF3', 'ATF4']",0.280316759532953,0,0,47
35,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.018043441827422055,11.403072421360644,45.78302781908628,"['MAS1', 'ACE2', 'REN', 'AGT']",0.3051919303381102,0,0,4
36,Sleep regulation WP3591,0.02160032068986731,2.318365102639296,8.891039404535125,"['CHRNB2', 'OXTR', 'AHCY', 'NPY2R', 'IL18', 'HCRTR2', 'HCRTR1', 'STAR', 'ADORA2A', 'CRH', 'GHRL', 'DRD3', 'PTGDR']",0.3284214622203697,0,0,13
37,Mitochondrial complex III assembly WP4921,0.02177712556229204,3.259527877541058,12.473871413486886,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.3284214622203697,0,0,8
38,Metabolic reprogramming in colon cancer WP4290,0.022030711592400158,2.0217302674494455,7.713543511836393,"['MDH2', 'PGAM1', 'SLC2A1', 'PYCR1', 'PYCR2', 'PDHB', 'ENO1', 'ACLY', 'LDHA', 'PKM', 'FASN', 'PGK1', 'ALDOB', 'TKT', 'SLC16A3', 'GAPDH', 'IDH3A']",0.3284214622203697,0,0,17
39,Ferroptosis WP4313,0.02219063933921417,2.075635296471687,7.904195078395099,"['PRNP', 'GPX4', 'ALOX15', 'NCOA4', 'ACSL5', 'SAT2', 'CP', 'MAP1LC3B', 'TF', 'MAP1LC3A', 'FTH1', 'PCBP1', 'VDAC3', 'HMOX1', 'VDAC2', 'FTL']",0.3284214622203697,0,0,16
40,Hematopoietic Stem Cell Differentiation WP2849,0.02219063933921417,2.075635296471687,7.904195078395099,"['CIITA', 'GYPA', 'TRAF3IP3', 'NOTCH1', 'RHOH', 'IKZF1', 'ABO', 'FLI1', 'RUNX1', 'MUC1', 'TPO', 'IL5', 'TRIM29', 'MYB', 'PIM1', 'FOSB']",0.3284214622203697,0,0,16
41,ACE Inhibitor Pathway WP554,0.02381380492670994,4.277140766040498,15.985770103968324,"['MAS1', 'ACE2', 'TGFB1', 'ATP6AP2', 'REN', 'AGT']",0.3356612503955306,0,0,6
42,EDA signaling in hair follicle development WP3930,0.02381380492670994,4.277140766040498,15.985770103968324,"['EDA', 'PTCH1', 'SOSTDC1', 'LTB', 'DKK1', 'RELB']",0.3356612503955306,0,0,6
43,Nanomaterial induced apoptosis WP2507,0.02472957234363207,2.852294921875,10.552793798067912,"['CASP7', 'ENDOG', 'CASP8', 'CASP6', 'BCL2', 'HTRA2', 'BAX', 'CYCS', 'FADD']",0.34046294947512057,0,0,9
44,Cori Cycle WP1946,0.029798785327489134,3.3269074345209044,11.688382792827408,"['LDHA', 'TPI1', 'PGAM1', 'SLC2A1', 'PGK1', 'ALDOA', 'GAPDH']",0.40092911167894474,0,0,7
45,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.032085983151097876,4.751626016260163,16.342438445579266,"['HSD11B1', 'HSD11B2', 'H6PD', 'STAR', 'HSD3B1']",0.4221089338988876,0,0,5
46,Adipogenesis WP236,0.034279942380707376,1.488695694323265,5.0216606732716675,"['CEBPA', 'CEBPB', 'CEBPD', 'SERPINE1', 'ASIP', 'UCP1', 'LPL', 'RORA', 'FOXO1', 'CYP26B1', 'E2F1', 'NDN', 'MEF2D', 'PCK2', 'FZD1', 'GDF10', 'WWTR1', 'EGR2', 'TGFB1', 'WNT5B', 'GADD45B', 'GADD45A', 'EBF1', 'HMGA1', 'MIF', 'IGF1', 'PRLR', 'AGT', 'SFRP4', 'KLF6', 'RBL1', 'KLF5', 'DDIT3', 'LEP', 'ID3', 'PLIN1', 'IL6ST']",0.4411679541169297,0,0,37
47,Inflammatory Response Pathway WP453,0.03637253256081569,2.566845703125,8.506376215201431,"['CD86', 'COL1A1', 'ZAP70', 'IL5', 'CD80', 'FN1', 'TNFRSF1B', 'THBS1', 'TNFRSF1A']",0.4581391335319764,0,0,9
48,Glycolysis in senescence WP5049,0.04103065980390356,3.4214198585020736,10.92608429224624,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.4714932518693846,0,0,6
49,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.04103065980390356,3.4214198585020736,10.92608429224624,"['ABCA1', 'LPL', 'APOA1', 'PCSK9', 'APOE', 'LDLRAP1']",0.4714932518693846,0,0,6
50,Transcriptional cascade regulating adipogenesis WP4211,0.04103065980390356,3.4214198585020736,10.92608429224624,"['CEBPA', 'CEBPB', 'EGR2', 'KLF5', 'CEBPD', 'DDIT3']",0.4714932518693846,0,0,6
51,Apoptosis Modulation and Signaling WP1772,0.04149603720080195,1.5732051525858013,5.006186332188369,"['HRK', 'HTRA2', 'TNFRSF11B', 'CASP7', 'BCL2L10', 'CASP8', 'CAPNS1', 'IRAK1', 'CASP6', 'PEA15', 'FADD', 'MAPK3', 'JUN', 'ENDOG', 'CRADD', 'BIK', 'CDKN2A', 'BAD', 'TNFRSF1B', 'TNFRSF1A', 'NFKBIA', 'TOLLIP', 'BCL2', 'CYCS', 'BAX', 'MAP3K14', 'BCL2L2']",0.4714932518693846,0,0,27
52,Cellular Proteostasis WP4918,0.04300783040700468,5.701048524750061,17.937625591103373,"['VBP1', 'PFDN2', 'PFDN5', 'PFDN6']",0.4714932518693846,0,0,4
53,Codeine and Morphine Metabolism WP1604,0.04300783040700468,5.701048524750061,17.937625591103373,"['ABCC3', 'ABCB1', 'ABCC2', 'CYP3A4']",0.4714932518693846,0,0,4
54,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.04300783040700468,5.701048524750061,17.937625591103373,"['CD86', 'TGFB1', 'IL5', 'CD80']",0.4714932518693846,0,0,4
55,PI3K-Akt signaling pathway WP4172,0.043850412530269646,1.26964130437673,3.9701317327429204,"['CHRM2', 'CDKN1B', 'CHRM1', 'CSF3R', 'ITGB4', 'LAMC3', 'TNC', 'FGF1', 'GYS2', 'GYS1', 'FGF7', 'CCND3', 'FGF8', 'MYC', 'CREB3L1', 'MYB', 'CREB3L2', 'TNR', 'ITGB8', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'HSP90AA1', 'SYK', 'HGF', 'F2R', 'FLT3LG', 'NGF', 'PRLR', 'CREB3', 'CCNE2', 'CDC37', 'KIT', 'COL4A3', 'ITGA8', 'COL4A5', 'COL6A6', 'SGK1', 'SGK2', 'TLR4', 'ATF4', 'PKN3', 'LAMA4', 'LAMA3', 'PDGFB', 'LPAR2', 'THBS1', 'EGFR', 'THBS4', 'PIK3R5', 'PPP2CA', 'GNG10', 'GNG3', 'CHAD', 'GNG8', 'PCK2', 'MAPK3', 'NTRK1', 'ANGPT2', 'ANGPT1', 'LAMB3', 'BAD', 'FN1', 'VEGFC', 'IGF1', 'GNG12', 'GNG11', 'VEGFA', 'COL1A1', 'EFNA1', 'FGF17', 'EFNA3', 'LPAR6', 'IL7', 'ITGA10', 'ITGA11', 'BCL2', 'GNB4', 'COL9A3', 'KRAS', 'FGFR4', 'FGF10']",0.471989894871266,0,0,83
56,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.046485994005616545,2.8513909224011713,8.749790205773866,"['CLDN4', 'TGFB1', 'TERT', 'ERBB4', 'CDH1', 'MYC', 'ALPL']",0.47520823243443544,0,0,7
57,Vitamin B12 metabolism WP1533,0.04889076095003495,1.9018984763301556,5.740246910463167,"['ABCA1', 'SERPINA3', 'CUBN', 'SERPINE1', 'APOA1', 'PLAT', 'PLG', 'SOD2', 'SOD1', 'TCN2', 'TCN1', 'ALB', 'SAA2', 'APOE']",0.47520823243443544,0,0,14
58,Complement Activation WP545,0.04964135701238333,2.534754427358772,7.61169260153735,"['C1QB', 'C3', 'C1QA', 'C6', 'C9', 'MASP2', 'C2', 'C1QC']",0.47520823243443544,0,0,8
59,Calcium Regulation in the Cardiac Cell WP536,0.05093906856216096,1.3812545494397255,4.112167581163006,"['CHRM2', 'RYR1', 'GNAZ', 'CHRM1', 'RGS14', 'YWHAB', 'CHRM5', 'CACNA1A', 'ATP2A2', 'ADRB1', 'ITPR3', 'ADRA1D', 'ADRA1B', 'ADRA1A', 'RYR3', 'RGS4', 'RGS2', 'GNG3', 'PLN', 'GRK5', 'RGS1', 'GNG8', 'GJA9', 'RGS9', 'YWHAG', 'YWHAH', 'KCNJ5', 'PRKCD', 'ATP1B1', 'GNG12', 'GNG11', 'GJD2', 'FKBP1A', 'SLC8A3', 'GJB1', 'PRKAR1A', 'FXYD2', 'GNB4', 'PRKCQ', 'CALM3', 'CALR', 'CASQ1', 'CALM1', 'CALM2']",0.47520823243443544,0,0,44
60,Heart Development WP1591,0.05107573463500896,2.0134806915681005,5.988989095660232,"['TBX1', 'NOTCH1', 'FGF8', 'HEY1', 'HEY2', 'BHLHE40', 'NFATC3', 'SMYD1', 'VEGFC', 'NFATC1', 'VEGFA', 'FGF10']",0.47520823243443544,0,0,12
61,Urea cycle and metabolism of amino groups WP497,0.05126237031898771,2.3332963423295454,6.93175284921468,"['OAT', 'CKM', 'ARG1', 'ODC1', 'PYCR1', 'PYCR3', 'CKB', 'ASS1', 'OTC']",0.47520823243443544,0,0,9
62,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.05170686437033218,2.091630027682788,6.195752702822059,"['RAB3B', 'EGR2', 'RAB3A', 'RAB25', 'HSPB8', 'HSPB1', 'NEFL', 'MFN2', 'RABAC1', 'RAB11A', 'DNM2']",0.47520823243443544,0,0,11
63,White fat cell differentiation WP4149,0.05170686437033218,2.091630027682788,6.195752702822059,"['CEBPA', 'CEBPB', 'EGR2', 'KLF5', 'CEBPD', 'IRF3', 'DDIT3', 'EBF1', 'RORA', 'ZNF423', 'FOXO1']",0.47520823243443544,0,0,11
64,G1 to S cell cycle control WP45,0.052638104724804596,1.609965020692427,4.740244155200937,"['CDKN2D', 'CDKN2B', 'CDKN1B', 'CDKN2C', 'CDKN2A', 'GADD45A', 'PRIM1', 'CDC25A', 'CREB3', 'CCND3', 'CCNE2', 'TFDP2', 'MYC', 'CREB3L1', 'RPA3', 'POLE2', 'CCNG2', 'MCM3', 'E2F1', 'MCM4', 'POLE', 'MCM2']",0.47520823243443544,0,0,22
65,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.05518673734628885,1.61973555337904,4.692426733966671,"['GRIA1', 'FZD1', 'JUN', 'CDKN1B', 'FZD5', 'FZD9', 'FN1', 'ELK1', 'EGFR', 'SOD1', 'PPP2CA', 'ACTA1', 'ERBB4', 'MYC', 'TMSB4X', 'NEFL', 'PFN4', 'NEFM', 'NOS1', 'NEFH', 'PFN2']",0.47520823243443544,0,0,21
66,COVID-19 adverse outcome pathway WP4891,0.05648694794989629,8.55021940516821,24.57115605516643,"['ACE2', 'IL7', 'AGT']",0.47520823243443544,0,0,3
67,Gastric acid production WP2596,0.05648694794989629,8.55021940516821,24.57115605516643,"['GRP', 'CCK', 'MUC6']",0.47520823243443544,0,0,3
68,Thyroxine (Thyroid Hormone) Production WP1981,0.05648694794989629,8.55021940516821,24.57115605516643,"['TPO', 'CGA', 'TSHR']",0.47520823243443544,0,0,3
69,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.05696048653986823,3.5634146341463415,10.210599277719629,"['CDH1', 'MYC', 'E2F1', 'BAX', 'IL6ST']",0.47520823243443544,0,0,5
70,Tamoxifen metabolism WP691,0.05696048653986823,3.5634146341463415,10.210599277719629,"['CYP2A6', 'CYP1B1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.47520823243443544,0,0,5
71,Folate Metabolism WP176,0.05699287922777858,1.755704798991666,5.029793926640326,"['ABCA1', 'SERPINA3', 'GPX2', 'AHCY', 'GPX4', 'GPX3', 'SERPINE1', 'APOA1', 'PLAT', 'PLG', 'SOD2', 'SOD1', 'RFK', 'ALB', 'SAA2', 'NOS1']",0.47520823243443544,0,0,16
72,NRF2 pathway WP2884,0.06047484593739612,1.4081882055097512,3.950711115988171,"['SRXN1', 'GSTP1', 'PDGFB', 'SLC2A1', 'KEAP1', 'SLC5A12', 'SLC2A3', 'TXN', 'SLC5A2', 'SLC5A3', 'DNAJB1', 'FTH1', 'SLC39A6', 'HMOX1', 'SLC39A7', 'SLC39A1', 'SLC39A4', 'GGT2', 'SLC39A3', 'CBR3', 'ABCC3', 'EGR1', 'HSP90AA1', 'GPX2', 'TGFB1', 'ABCC2', 'GPX3', 'HGF', 'SLC2A12', 'SLC39A11', 'NRG1', 'CES4A', 'CYP2A6', 'SLC5A9', 'MAFF', 'FTL']",0.4972376221519236,0,0,36
73,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.0656252791905435,1.9014577734343188,5.179179852096436,"['NFKBIA', 'NDUFA13', 'CASP7', 'HSP90AA1', 'CASP8', 'AIM2', 'IL18', 'NLRC4', 'RAC1', 'NLRP1', 'IKBKG', 'AAMP']",0.5169091456422675,0,0,12
74,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.06576889710320297,1.522110593808707,4.14258873552548,"['FZD1', 'WNT10A', 'JUN', 'WNT5B', 'FZD5', 'SERPINF1', 'TCF7', 'FZD9', 'WNT7A', 'DKK1', 'CXXC4', 'DKK2', 'NKD1', 'SFRP4', 'WNT6', 'FRAT1', 'CCND3', 'FRAT2', 'SFRP2', 'MYC', 'ROR1', 'NOTUM', 'WNT2', 'WNT4']",0.5169091456422675,0,0,24
75,Nicotine Metabolism WP1600,0.06751453266212834,inf,inf,"['CYP2A6', 'AOX1']",0.5169091456422675,0,0,2
76,Biomarkers for pyrimidine metabolism disorders WP4584,0.0681062725677312,2.4947535383113713,6.7026193097278375,"['NT5C', 'RRM2', 'RRM2B', 'DPYS', 'CKB', 'UPB1', 'TYMP']",0.5169091456422675,0,0,7
77,Hypertrophy Model WP516,0.0681062725677312,2.4947535383113713,6.7026193097278375,"['NR4A3', 'ZEB1', 'MSTN', 'WDR1', 'IL18', 'ATF3', 'VEGFA']",0.5169091456422675,0,0,7
78,Overview of nanoparticle effects WP3287,0.0681062725677312,2.4947535383113713,6.7026193097278375,"['CCND3', 'CDH3', 'LAMA3', 'FN1', 'BCL2', 'HMOX1', 'BAX']",0.5169091456422675,0,0,7
79,Kynurenine Pathway and links to Cellular Senescence WP5044,0.06957080024132378,2.281083719794972,6.080024125014027,"['KLF5', 'HAAO', 'NOS1', 'KMO', 'TLR4', 'FOXO1', 'ACMSD', 'IDO1']",0.5213406802894136,0,0,8
80,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.07368064744066743,1.3457241605575165,3.509668931003027,"['CHRM2', 'TPH1', 'CEBPB', 'YWHAB', 'CDCA7L', 'ATP1A3', 'RORA', 'FOXM1', 'NEUROD1', 'MYB', 'HES1', 'PKNOX1', 'YWHAG', 'YWHAH', 'NKX3-1', 'CHRNB2', 'EGR1', 'GABRA1', 'JUN', 'TSPYL1', 'CAV3', 'SSTR1', 'POU2F2', 'NGF', 'POU3F2', 'GCK', 'VEGFA', 'ADCYAP1', 'AR', 'TF', 'REST', 'PRKAR1A', 'SST', 'KCNQ1', 'PAH', 'BHLHE40', 'CHRFAM7A', 'ALDOA', 'GAPDH', 'SCN4B', 'SLC25A4']",0.545236791060939,0,0,41
81,Oxidation by Cytochrome P450 WP43,0.07604175348413976,1.7362184221993135,4.473319368820075,"['CYP3A43', 'CYP51A1', 'CYP3A4', 'CYP2C19', 'CYP3A5', 'CYP2C18', 'CYP3A7', 'CYP27A1', 'CYP39A1', 'CYB5R1', 'CYP26B1', 'CYP2A6', 'CYP24A1', 'CYP1B1']",0.555761951390256,0,0,14
82,Alzheimer's disease WP2059,0.07892410223290308,1.4549221502771248,3.6944381600756184,"['ATP5MD', 'ATP2A2', 'LPL', 'ITPR3', 'RYR3', 'APH1A', 'CASP7', 'CASP8', 'PPP3R2', 'CHP1', 'NOS1', 'CAPN1', 'FADD', 'APOE', 'MAPK3', 'PSENEN', 'MME', 'BAD', 'TNFRSF1A', 'PLCB4', 'CYCS', 'CALM3', 'CALM1', 'GAPDH', 'CALM2', 'CDK5R1']",0.5635974628364291,0,0,26
83,Microglia Pathogen Phagocytosis Pathway WP3937,0.07933991518371664,1.7656169994879671,4.474098076902041,"['C1QB', 'VAV3', 'LYN', 'C1QA', 'FCER1G', 'SYK', 'NCF2', 'CYBA', 'VAV2', 'HCK', 'PTPN6', 'RAC1', 'C1QC']",0.5635974628364291,0,0,13
84,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.07996991026733115,3.8003738925465336,9.600142871299022,"['HEY1', 'VEGFC', 'HES1', 'VEGFA']",0.5635974628364291,0,0,4
85,Melanoma WP4685,0.08482684737882196,1.4945826481462043,3.6873494020299113,"['GADD45B', 'CALML6', 'CDKN2A', 'BAD', 'GADD45A', 'MITF', 'ELK1', 'GADD45G', 'PREX2', 'CDH1', 'ERBB4', 'KIT', 'E2F1', 'BAX', 'KRAS', 'CALM3', 'RAC1', 'CALM1', 'HRAS', 'LAMTOR3', 'CALM2', 'MAPK3']",0.5800133939851638,0,0,22
86,Endothelin Pathways WP2197,0.08585761034945238,1.8452398057415442,4.530183753204905,"['CNN1', 'ADCY10', 'GNA15', 'EDNRA', 'EDNRB', 'NPY', 'ATP2A2', 'ADRB1', 'CALM1', 'ADRA1A', 'CALM2']",0.5800133939851638,0,0,11
87,Striated Muscle Contraction Pathway WP383,0.08890401986544884,1.901017501017501,4.600838601181755,"['ACTA2', 'MYOM1', 'ACTA1', 'MYBPC1', 'ACTC1', 'TCAP', 'DMD', 'VIM', 'MYL9', 'ACTG1']",0.5800133939851638,0,0,10
88,Cytokines and Inflammatory Response WP530,0.09010719491156262,2.850487804878049,6.860426525999433,"['TGFB1', 'IL5', 'IL15', 'IL7', 'HLA-DRA']",0.5800133939851638,0,0,5
89,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.09017203231947883,1.4268202990929149,3.4329809523131303,"['TCF7', 'CXXC4', 'NKD1', 'WNT6', 'FRAT1', 'CCND3', 'FRAT2', 'MYC', 'WNT2', 'WNT4', 'FZD1', 'WNT10A', 'JUN', 'WNT5B', 'FZD5', 'SERPINF1', 'FZD9', 'WNT7A', 'DKK1', 'DKK2', 'SFRP4', 'SFRP2', 'HNRNPK', 'ROR1', 'NOTUM', 'ATF3']",0.5800133939851638,0,0,26
90,Constitutive Androstane Receptor Pathway WP2875,0.09161037171961925,1.9739896334134615,4.71825131191798,"['ABCC3', 'HSP90AA1', 'CYP2A6', 'ABCB1', 'ABCC2', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FOXO1']",0.5800133939851638,0,0,9
91,Urea cycle and associated pathways WP4595,0.09161037171961925,1.9739896334134615,4.71825131191798,"['SLC25A15', 'OAT', 'GOT1', 'MDH2', 'ARG1', 'PYCR1', 'NOS1', 'ASS1', 'OTC']",0.5800133939851638,0,0,9
92,Zinc homeostasis WP3529,0.09161037171961925,1.9739896334134615,4.71825131191798,"['SLC30A3', 'SLC30A2', 'SLC39A6', 'SLC39A11', 'SLC30A1', 'SLC39A7', 'SLC39A1', 'SLC39A4', 'SLC39A3']",0.5800133939851638,0,0,9
93,Prostaglandin Synthesis and Regulation WP98,0.09267873954178799,1.66373339851707,3.9573831802879194,"['HPGD', 'ANXA3', 'PTGER3', 'AKR1C3', 'MITF', 'HSD11B1', 'HSD11B2', 'EDNRA', 'EDNRB', 'SCGB1A1', 'TBXAS1', 'S100A6', 'PTGDR', 'PTGES']",0.5800133939851638,0,0,14
94,Imatinib and Chronic Myeloid Leukemia WP3640,0.09371500858863045,2.0735349590609538,4.909087640545249,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'MYC', 'KIT', 'PIM1', 'PIM2']",0.5800133939851638,0,0,8
95,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.09371500858863045,2.0735349590609538,4.909087640545249,"['CD86', 'LDHA', 'CYP24A1', 'VDR', 'CD80', 'MYC', 'HLA-DRA', 'SLC2A3']",0.5800133939851638,0,0,8
96,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.09405622605164819,2.443453107029589,5.775987233859412,"['POSTN', 'NOTCH1', 'TCF7', 'TNC', 'WNT2', 'VEGFA']",0.5800133939851638,0,0,6
97,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.0973326046316646,1.6852172753932284,3.9259179791132017,"['CALML6', 'HSD3B1', 'ITPR3', 'AGT', 'CREB3', 'STAR', 'CREB3L1', 'CREB3L2', 'CALM3', 'REN', 'CALM1', 'CALM2', 'ATF4']",0.5907972506022909,0,0,13
98,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.09794522203987784,1.4596996052833928,3.3913885752932424,"['HSPA8', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBB4B', 'SNCAIP', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1C', 'TUBB6', 'PSMC5', 'CASP8', 'TUBA1A', 'PSMD7', 'TUBB2A', 'TUBB3', 'PSMD2', 'PSMD3', 'TUBB1', 'STUB1', 'HSPA1B']",0.5907972506022909,0,0,22
99,Endochondral Ossification with Skeletal Dysplasias WP4808,0.0997968328720086,1.5055745907434601,3.4697755531785717,"['TGFB1', 'HMGCS1', 'PTCH1', 'PLAT', 'CTSV', 'IGF1', 'VEGFA', 'ADAMTS5', 'ACAN', 'SCIN', 'ADAMTS1', 'COL10A1', 'TIMP3', 'ALPL', 'SOX6', 'CALM1', 'SLC38A2', 'CALM2', 'SOX5']",0.5907972506022909,0,0,19
100,Endochondral Ossification WP474,0.0997968328720086,1.5055745907434601,3.4697755531785717,"['TGFB1', 'HMGCS1', 'PTCH1', 'PLAT', 'CTSV', 'IGF1', 'VEGFA', 'ADAMTS5', 'ACAN', 'SCIN', 'ADAMTS1', 'COL10A1', 'TIMP3', 'ALPL', 'SOX6', 'CALM1', 'SLC38A2', 'CALM2', 'SOX5']",0.5907972506022909,0,0,19
101,Genotoxicity pathway WP4286,0.10544935937520529,1.5101253616200578,3.3970639193432866,"['IKBIP', 'PLK3', 'BTG2', 'CEBPD', 'GADD45A', 'EI24', 'PCDH8', 'TRIAP1', 'ACTA2', 'RPS27', 'RRM2B', 'SERTAD1', 'BLOC1S2', 'ID2', 'HIST1H1E', 'B3GNT2', 'TRIM22', 'PHLDA3']",0.6180794133675399,0,0,18
102,7-oxo-C and 7beta-HC pathways WP5064,0.11215225118272247,1.7820512820512822,3.898946338339171,"['HSD11B1', 'CYP27A1', 'HSD11B2', 'DBP', 'ACOX2', 'ACOT11', 'THEM5', 'ACOT12', 'ACOT6', 'ACOT4']",0.6497897653084783,0,0,10
103,Composition of Lipid Particles WP3601,0.11415225606770564,4.274744027303754,9.27714414003272,"['APOA1', 'LPL', 'APOE']",0.6497897653084783,0,0,3
104,miR-517 relationship with ARCN1 and USP1 WP3596,0.11415225606770564,4.274744027303754,9.27714414003272,"['ID2', 'USP1', 'ARCN1']",0.6497897653084783,0,0,3
105,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.11878112897186592,1.4262977473065621,3.0386884579350113,"['YAP1', 'ANGPT2', 'ANGPT1', 'BAD', 'FN1', 'FOXO1', 'EGFR', 'NFKBIA', 'CASP7', 'RAD51', 'MYC', 'TNIP3', 'STMN1', 'BAX', 'KRAS', 'NOS1', 'RAC1', 'IKBKG', 'HRAS', 'ANGPTL1', 'MAPK3']",0.6517190043668415,0,0,21
106,Breast cancer pathway WP4262,0.12019510858208414,1.2720386853817185,2.694990706921129,"['SHC4', 'NOTCH3', 'NOTCH1', 'SHC3', 'TCF7', 'FGF1', 'EGFR', 'DLL3', 'WNT6', 'FRAT1', 'FGF7', 'FRAT2', 'FGF8', 'HEY1', 'MYC', 'HEY2', 'E2F1', 'HES1', 'WNT2', 'HRAS', 'SKP1', 'WNT4', 'MAPK3', 'FZD1', 'WNT10A', 'JUN', 'WNT5B', 'GADD45B', 'FZD5', 'GADD45A', 'FZD9', 'WNT7A', 'IGF1', 'GADD45G', 'FGF17', 'SFRP4', 'RAD51', 'KIT', 'BAX', 'KRAS', 'FGF10']",0.6517190043668415,0,0,41
107,Globo Sphingolipid Metabolism WP1424,0.12201677859065355,1.9005776584492717,3.9980489175356992,"['B3GALNT1', 'ST6GALNAC1', 'ST6GAL2', 'ST6GALNAC2', 'FUT2', 'ST6GALNAC3', 'FUT1', 'ABO']",0.6517190043668415,0,0,8
108,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.12417698841515731,1.6294021151094202,3.399010054104465,"['LDHA', 'ANGPT2', 'PKM', 'ANGPT1', 'IGFBP3', 'SERPINE1', 'IGFBP2', 'SLC2A1', 'PGK1', 'BAX', 'SLC2A3', 'VEGFA']",0.6517190043668415,0,0,12
109,Matrix Metalloproteinases WP129,0.12638292249848895,1.9954612005856516,4.127489597097854,"['MMP16', 'MMP26', 'TIMP2', 'TIMP3', 'MMP19', 'MMP21', 'TIMP4']",0.6517190043668415,0,0,7
110,Pyrimidine metabolism and related diseases WP4225,0.12638292249848895,1.9954612005856516,4.127489597097854,"['NT5C', 'RRM2', 'RRM2B', 'DPYS', 'UPB1', 'TYMP', 'OTC']",0.6517190043668415,0,0,7
111,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.12638292249848895,1.9954612005856516,4.127489597097854,"['CDH6', 'TGFB1', 'CDH1', 'TNC', 'FN1', 'VIM', 'MAPK3']",0.6517190043668415,0,0,7
112,HIF1A and PPARG regulation of glycolysis WP2456,0.12785386513421776,2.8500365764447695,5.862147168746809,"['LDHA', 'TPI1', 'SLC2A1', 'GAPDH']",0.6517190043668415,0,0,4
113,Irinotecan pathway WP229,0.12785386513421776,2.8500365764447695,5.862147168746809,"['ABCC1', 'ABCC2', 'CYP3A4', 'CYP3A5']",0.6517190043668415,0,0,4
114,Macrophage markers WP4146,0.12785386513421776,2.8500365764447695,5.862147168746809,"['CD86', 'CD74', 'CD83', 'CD68']",0.6517190043668415,0,0,4
115,Urea cycle and related diseases WP4571,0.12785386513421776,2.8500365764447695,5.862147168746809,"['SLC25A15', 'ARG1', 'ASS1', 'OTC']",0.6517190043668415,0,0,4
116,ID signaling pathway WP53,0.12973391529154626,2.1378384971944375,4.3660428537522185,"['RBL1', 'PAX8', 'ID2', 'ID3', 'ELK1', 'PAX2']",0.6517190043668415,0,0,6
117,Biomarkers for urea cycle disorders WP4583,0.13100432689130767,2.37520325203252,4.827659815549295,"['F10', 'GOT1', 'ARG1', 'ASS1', 'OTC']",0.6517190043668415,0,0,5
118,Farnesoid X receptor pathway WP2879,0.13100432689130767,2.37520325203252,4.827659815549295,"['SLC10A1', 'ABCB4', 'CYP3A4', 'ABCB11', 'FKBP5']",0.6517190043668415,0,0,5
119,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.13100432689130767,2.37520325203252,4.827659815549295,"['ZAP70', 'CD8B', 'IGLL1', 'HLA-DRA', 'CD247']",0.6517190043668415,0,0,5
120,Aryl Hydrocarbon Receptor Netpath WP2586,0.13219608792348872,1.535490664310024,3.107017673200858,"['HSP90AA1', 'CDKN1B', 'AIP', 'LPL', 'EGFR', 'VEGFA', 'KLF6', 'PSRC1', 'MYC', 'CDC37', 'E2F1', 'CYP1B1', 'KRAS', 'HRAS']",0.6521673670892111,0,0,14
121,Metapathway biotransformation Phase I and II WP702,0.13395855219856603,1.2721475873997465,2.5573026788473996,"['HS3ST3A1', 'GAL3ST1', 'GSTP1', 'GLYAT', 'CYP2C19', 'CYP3A4', 'CYP2C18', 'CYP3A5', 'NAA80', 'CYP3A7', 'SULT1C2', 'CYP26B1', 'NDST4', 'CYP1B1', 'CHST13', 'GAL3ST2', 'SULT4A1', 'SULT1C4', 'CHST9', 'GPX2', 'CHST6', 'GPX4', 'GPX3', 'CYP3A43', 'CYP51A1', 'AKR1C3', 'KCNAB1', 'HS3ST5', 'FMO5', 'HS3ST4', 'CYP27A1', 'CYP39A1', 'CYP2A6', 'CYP24A1', 'NAT8L', 'CHST4', 'CHST2']",0.6554005198475297,0,0,37
122,Prader-Willi and Angelman Syndrome WP3998,0.1411261240467529,1.4259848299486175,2.7922227373847526,"['PCSK1', 'OCA2', 'MAGEL2', 'CDKN2B', 'CDKN2C', 'CDKN2A', 'ATP10A', 'NGF', 'TYR', 'NHLH2', 'GABRR1', 'FEZ1', 'E2F1', 'NDN', 'GNRH1', 'GHRL', 'CGA', 'GABRD']",0.6848087330793255,0,0,18
123,Pathways in clear cell renal cell carcinoma WP4018,0.1453296173876374,1.3244492697790076,2.5545327119012806,"['BHLHE41', 'SLC2A1', 'PDGFB', 'PLOD2', 'ENO1', 'ENO2', 'SDSL', 'ACACB', 'EGFR', 'LDHC', 'LDHA', 'PGK1', 'CEP290', 'TPI1', 'TGFB1', 'VEGFA', 'ACLY', 'PKM', 'ZEB1', 'FASN', 'ALDOC', 'ALDOB', 'ALDOA', 'GAPDH', 'PFKM', 'BAP1']",0.6979699998247405,0,0,26
124,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.14619641888220916,1.710498046875,3.2889528741499876,"['ABCA1', 'ABCC3', 'ABCB1', 'ABCC2', 'CYP24A1', 'VDR', 'ABCB4', 'CYP3A4', 'ABCB11']",0.6979699998247405,0,0,9
125,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.15425112080440043,1.7542291733163102,3.2789584206748277,"['GSK3A', 'BCL2L10', 'ITGB4', 'MYC', 'BCL2', 'BAX', 'BCL2L14', 'BCL2L2']",0.7305333081296403,0,0,8
126,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.1684993012388764,1.2186167158792651,2.170141499788256,"['NOTCH3', 'NOTCH1', 'EIF5A2', 'TWIST2', 'WNT8A', 'CLDN2', 'FOXM1', 'DLL3', 'FOXQ1', 'WNT6', 'CLDN20', 'CDH1', 'WNT2', 'HRAS', 'MEF2D', 'WNT4', 'MAPK3', 'FZD1', 'DSP', 'WNT10A', 'TGFB1', 'WNT5B', 'FZD5', 'JUP', 'GDF15', 'FZD9', 'FN1', 'WNT7A', 'WNT9A', 'CLDN5', 'CLDN4', 'ZEB1', 'CLDN9', 'CLDN14', 'ID2', 'COL4A3', 'PKP2', 'COL4A5', 'STRAP', 'CLDN18', 'KRAS']",0.7617753359616942,0,0,41
127,Dopaminergic Neurogenesis WP2855,0.1708190200718313,1.900138245100431,3.357830525595517,"['NEUROD1', 'FGF8', 'TGFB1', 'ALDH1A1', 'SLC18A2', 'GLI2']",0.7617753359616942,0,0,6
128,miRNAs involved in DNA damage response WP1545,0.1708190200718313,1.900138245100431,3.357830525595517,"['CCND3', 'CDKN1B', 'MYC', 'H2AFX', 'E2F1', 'CDC25A']",0.7617753359616942,0,0,6
129,TP53 network WP1742,0.1708190200718313,1.900138245100431,3.357830525595517,"['SUMO1', 'CDKN2A', 'GADD45A', 'MYC', 'BCL2', 'BAX']",0.7617753359616942,0,0,6
130,Circadian rhythm related genes WP3594,0.17412396956206283,1.1890669954788327,2.0784745595121183,"['CHRM1', 'SUV39H1', 'SERPINE1', 'NPY2R', 'BHLHE41', 'RORA', 'CCAR2', 'PPP1CC', 'HTR7', 'DBP', 'SKP1', 'CHRNB2', 'KLF10', 'CARTPT', 'CLDN4', 'ADORA2A', 'CRH', 'UBA52', 'ATF4', 'TPH1', 'MAGEL2', 'AHCY', 'CIPC', 'OPRL1', 'RBM4B', 'RELB', 'CIART', 'ATOH7', 'PROKR2', 'NFIL3', 'NOCT', 'UBC', 'RPS27A', 'DRD3', 'NTRK1', 'EGR1', 'JUN', 'ZFHX3', 'EGR3', 'NR1D2', 'HCRTR2', 'NR2F6', 'HCRTR1', 'PER2', 'STAR', 'ID2', 'LEP', 'BHLHE40', 'ID3', 'GHRL']",0.7617753359616942,0,0,50
131,Bladder cancer WP2828,0.17539930847096288,1.4874600325051255,2.589207014657312,"['RPS6KA5', 'CDH1', 'CDKN2A', 'MYC', 'DAPK2', 'E2F1', 'KRAS', 'THBS1', 'HRAS', 'EGFR', 'TYMP', 'VEGFA']",0.7617753359616942,0,0,12
132,Oxysterols derived from cholesterol WP4545,0.17539930847096288,1.4874600325051255,2.589207014657312,"['CYP39A1', 'CYP27A1', 'DBP', 'ACOX2', 'INSIG1', 'GPR183', 'ACOT11', 'THEM5', 'ACOT12', 'CYP3A4', 'ACOT6', 'ACOT4']",0.7617753359616942,0,0,12
133,Ovarian infertility WP34,0.17842339829662865,1.60345458984375,2.7637077746334726,"['EGR1', 'CEBPB', 'LHCGR', 'CDKN1B', 'VDR', 'SMPD1', 'FSHR', 'MSH5', 'PRLR']",0.7617753359616942,0,0,9
134,Photodynamic therapy-induced unfolded protein response WP3613,0.17842339829662865,1.60345458984375,2.7637077746334726,"['PPP1R15A', 'NARS', 'XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR', 'ATF3', 'ATF4']",0.7617753359616942,0,0,9
135,Genes targeted by miRNAs in adipocytes WP1992,0.1785796180317246,2.0357142857142856,3.5069672162663075,"['KCNE1', 'TMSB4X', 'KCNQ1', 'IGF1', 'ERG']",0.7617753359616942,0,0,5
136,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.1785796180317246,2.0357142857142856,3.5069672162663075,"['JUN', 'ITPR3', 'PRKCQ', 'RYR3', 'MAPK3']",0.7617753359616942,0,0,5
137,Osteoclast Signaling WP12,0.1785796180317246,2.0357142857142856,3.5069672162663075,"['AIMP2', 'ATP6V1G1', 'GPR68', 'PDGFB', 'TNFRSF11B']",0.7617753359616942,0,0,5
138,Platelet-mediated interactions with vascular and circulating cells WP4462,0.1785796180317246,2.0357142857142856,3.5069672162663075,"['SELP', 'TGFB1', 'SELPLG', 'SELE', 'TLR4']",0.7617753359616942,0,0,5
139,Bile acids synthesis and enterohepatic circulation  WP4389,0.18456858224736264,2.2798341867837113,3.8523137161126635,"['SLC10A1', 'FGFR4', 'ABCB11', 'MAPK3']",0.7617753359616942,0,0,4
140,PTF1A related regulatory pathway WP4147,0.18456858224736264,2.2798341867837113,3.8523137161126635,"['KAT2B', 'NOTCH1', 'HES1', 'FGF10']",0.7617753359616942,0,0,4
141,Role of Osx and miRNAs in tooth development WP3971,0.18456858224736264,2.2798341867837113,3.8523137161126635,"['NOTCH3', 'NOTCH1', 'ALPL', 'DKK1']",0.7617753359616942,0,0,4
142,Fatty Acid Omega Oxidation WP206,0.18529670334203374,2.8495855680156024,4.803822621629631,"['CYP2A6', 'ALDH1A1', 'CYP3A4']",0.7617753359616942,0,0,3
143,FOXP3 in COVID-19 WP5063,0.18529670334203374,2.8495855680156024,4.803822621629631,"['CD86', 'CD80', 'IL6ST']",0.7617753359616942,0,0,3
144,SARS-CoV-2 and COVID-19 Pathway WP4846,0.18529670334203374,2.8495855680156024,4.803822621629631,"['ACE2', 'NRP1', 'FURIN']",0.7617753359616942,0,0,3
145,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.19004583927950755,1.6287876146309146,2.70458550803023,"['ABCC3', 'JUN', 'ABCC2', 'SRXN1', 'GSTP1', 'ABCC6', 'KEAP1', 'HMOX1']",0.7705968277634827,0,0,8
146,Unfolded protein response WP4925,0.19004583927950755,1.6287876146309146,2.70458550803023,"['PPP1R15A', 'XBP1', 'CASP8', 'HSPA5', 'DDIT3', 'BCL2', 'TXNIP', 'ATF4']",0.7705968277634827,0,0,8
147,Modulators of TCR signaling and T cell activation WP5072,0.19417956832784,1.3464340073929115,2.206767554612715,"['MAP4K1', 'ITK', 'CDKN1B', 'NDUFB10', 'RHOH', 'RNF7', 'NFKBIA', 'ZAP70', 'FIBP', 'CD5', 'ELOB', 'PRKCQ', 'PTPN6', 'IKBKG', 'CD247', 'MEF2D', 'MAP3K14']",0.7820020710889883,0,0,17
148,IL-3 signaling pathway WP286,0.2062402045296926,1.376292787363346,2.1727723448001246,"['CD86', 'LYN', 'JUN', 'TGFB1', 'SYK', 'YWHAB', 'BAD', 'HCK', 'INPP5D', 'BCL2', 'PTPN6', 'JAK2', 'HRAS', 'MAPK3']",0.8249608181187704,0,0,14
149,Cancer immunotherapy by PD-1 blockade WP4585,0.21644036774143766,1.7099780434252256,2.617019151024583,"['ZAP70', 'JUN', 'CD8B', 'NFATC3', 'NFATC1', 'PDCD1LG2']",0.851323760647346,0,0,6
150,NOTCH1 regulation of endothelial cell calcification WP3413,0.21644036774143766,1.7099780434252256,2.617019151024583,"['NOTCH1', 'ALPL', 'PLAT', 'SOX6', 'VEGFA', 'DLL3']",0.851323760647346,0,0,6
151,Amyotrophic lateral sclerosis (ALS) WP2447,0.21834746355449688,1.425256472887152,2.1687666186296273,"['GRIA1', 'BAD', 'BCL2', 'NEFL', 'BAX', 'NEFM', 'NOS1', 'RAC1', 'NEFH', 'SOD1', 'TNFRSF1A']",0.851323760647346,0,0,11
152,7q11.23 copy number variation syndrome WP4932,0.21992622642828089,1.2162154361253825,1.8419134279804628,"['ATP5MC2', 'ATP5MC3', 'UBE2L6', 'ACACB', 'ATP5MC1', 'GRIP1', 'ATP5F1B', 'MYC', 'CFL1', 'BCL7B', 'EIF4H', 'WNT2', 'PRKG1', 'MAPK3', 'ATP5PB', 'H2AFX', 'FZD9', 'HMGA1', 'VPS37D', 'NRG1', 'ATP5F1D', 'ATP5F1E', 'CLIP2', 'CLDN5', 'CLDN4', 'TBL2', 'GTF2IRD1', 'GAPDH', 'ATF4']",0.851323760647346,0,0,29
153,DNA Replication WP466,0.22002117462676343,1.3725516816914667,2.078086466302968,"['CDT1', 'PRIM1', 'POLD4', 'POLD1', 'RPA3', 'POLE2', 'UBC', 'POLD2', 'MCM3', 'MCM4', 'POLE', 'UBA52', 'MCM2']",0.851323760647346,0,0,13
154,DNA Mismatch Repair WP531,0.22891002438640662,1.5200715971035716,2.2412334787027546,"['POLE4', 'POLD4', 'POLD1', 'RPA3', 'POLE2', 'POLD2', 'POLE3', 'POLE']",0.8695531781272774,0,0,8
155,Nephrogenesis WP5052,0.231406740922799,1.7810975609756097,2.6067758002828274,"['FGF8', 'ALDH1A2', 'RSPO3', 'PAX2', 'WNT4']",0.8695531781272774,0,0,5
156,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.231406740922799,1.7810975609756097,2.6067758002828274,"['JUN', 'IRAK1', 'TIFA', 'TLR9', 'TLR4']",0.8695531781272774,0,0,5
157,Pathogenic Escherichia coli infection WP2272,0.23246827913819998,1.3032316668413513,1.9014169529595022,"['TUBB', 'ARPC5L', 'LY96', 'TUBB4B', 'ACTB', 'TUBA4A', 'ACTG1', 'TUBB8', 'TUBA1C', 'TUBB6', 'TUBA1A', 'TUBB2A', 'CDH1', 'TUBB3', 'TUBB1', 'TLR4']",0.8695531781272774,0,0,16
158,Base Excision Repair WP4752,0.23383508927653124,1.4251526251526252,2.0709450868140533,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'POLD1', 'APEX1', 'POLE2', 'POLD2', 'POLE3', 'POLE']",0.8695531781272774,0,0,10
159,Genes controlling nephrogenesis WP4823,0.23383508927653124,1.4251526251526252,2.0709450868140533,"['ROBO2', 'KIRREL1', 'FGF8', 'EYA1', 'PDGFB', 'ITGA8', 'ETV4', 'PAX2', 'WNT4', 'VEGFA']",0.8695531781272774,0,0,10
160,Oxidative Damage WP3941,0.23510254856722762,1.3682286831175177,1.9808304771429557,"['C1QB', 'C1QA', 'CDKN1B', 'BAD', 'GADD45A', 'C5AR1', 'BCL2', 'CYCS', 'TNFRSF1B', 'NFKBIE', 'C2', 'C1QC']",0.8695531781272774,0,0,12
161,Apoptosis WP254,0.23648321229474945,1.2473677766895201,1.7985522268713372,"['HRK', 'JUN', 'CRADD', 'CDKN2A', 'BAD', 'IGF1', 'TNFRSF1B', 'TNFRSF1A', 'NFKBIA', 'CASP7', 'CASP8', 'IRF3', 'CASP6', 'MYC', 'BCL2', 'CYCS', 'BAX', 'IKBKG', 'FADD', 'NFKBIE', 'BCL2L2']",0.8695531781272774,0,0,21
162,Gene regulatory network modelling somitogenesis  WP2854,0.24754284203312915,1.8996992603430058,2.6523061802042216,"['NOTCH1', 'FGF8', 'HES1', 'TBX6']",0.8935759925831545,0,0,4
163,Nanoparticle triggered regulated necrosis WP2513,0.24754284203312915,1.8996992603430058,2.6523061802042216,"['CASP8', 'FADD', 'TNFRSF1A', 'FTL']",0.8935759925831545,0,0,4
164,Cytosolic DNA-sensing pathway WP4655,0.24754470064803602,1.2957323849744387,1.8090550450719654,"['CCL4L2', 'IL18', 'ISG15', 'NFKBIA', 'CASP8', 'AIM2', 'IRF3', 'POLR1C', 'POLR2E', 'POLR3H', 'IKBKG', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.8935759925831545,0,0,15
165,Tryptophan metabolism WP465,0.2516888855215859,1.3631719802043287,1.880579630103375,"['TPH1', 'HAAO', 'ALDH1A2', 'ALDH1A1', 'AOX1', 'CYP1B1', 'DHCR24', 'CYP3A4', 'CYP2C18', 'ACMSD', 'IDO1']",0.9030292135077507,0,0,11
166,TNF-alpha signaling pathway WP231,0.2569569279336271,1.1956599103195755,1.6247186474758422,"['TXN', 'PPP2CA', 'CASP7', 'CASP8', 'PSMD2', 'RFK', 'RAC1', 'IKBKG', 'FADD', 'HRAS', 'SKP1', 'MAPK3', 'HSP90AA1', 'JUN', 'BAD', 'CYBA', 'KSR2', 'TNFRSF1B', 'SELE', 'TNFRSF1A', 'NFKBIA', 'CDC37', 'BAX', 'KRAS', 'NFKBIE', 'MAP3K14']",0.9039432777481415,0,0,26
167,Benzo(a)pyrene metabolism WP696,0.2642917974358497,2.137006338371526,2.8437175248187314,"['AKR1C3', 'CYP1B1', 'CYP3A4']",0.9039432777481415,0,0,3
168,Dual hijack model of Vif in HIV infection WP3300,0.2642917974358497,2.137006338371526,2.8437175248187314,"['ELOB', 'ELOC', 'RUNX1']",0.9039432777481415,0,0,3
169,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2642917974358497,2.137006338371526,2.8437175248187314,"['CEBPB', 'ALDH1L1', 'ALDH1A1']",0.9039432777481415,0,0,3
170,Nucleotide GPCRs WP80,0.2642917974358497,2.137006338371526,2.8437175248187314,"['P2RY6', 'ADORA2A', 'LPAR6']",0.9039432777481415,0,0,3
171,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.2642917974358497,2.137006338371526,2.8437175248187314,"['NFKBIA', 'MUC1', 'IKBKG']",0.9039432777481415,0,0,3
172,BMP Signaling Pathway in Eyelid Development WP3927,0.26556260851119573,1.5543924238727849,2.0609761466210506,"['JUN', 'NOTCH1', 'DKK2', 'EGFR', 'MAPK3', 'FGF10']",0.9039432777481415,0,0,6
173,Fas ligand pathway and stress induction of heat shock proteins WP314,0.26755630140579784,1.3154917401191528,1.7343775424507193,"['ACTA1', 'CASP7', 'JUN', 'CASP8', 'CASP6', 'ARHGDIB', 'BCL2', 'HSPB1', 'CYCS', 'FADD', 'ACTB', 'ACTG1']",0.9039432777481415,0,0,12
174,Cardiac Progenitor Differentiation WP2406,0.2700392249671514,1.3571719286005,1.7767932746270996,"['MESP1', 'NOTCH1', 'TGFB1', 'ACTC1', 'KIT', 'NRG1', 'THY1', 'IGF1', 'DKK1', 'NODAL']",0.9039432777481415,0,0,10
175,miRNA regulation of prostate cancer signaling pathways WP3981,0.2700392249671514,1.3571719286005,1.7767932746270996,"['NFKBIA', 'AR', 'CDKN1B', 'BAD', 'CREB3L1', 'TCF7', 'BCL2', 'KRAS', 'IKBKG', 'FOXO1']",0.9039432777481415,0,0,10
176,Canonical and non-canonical Notch signaling WP3845,0.270266824596995,1.4249450817671467,1.8643205834030612,"['NOTCH3', 'NOTCH1', 'MAML2', 'HEY1', 'CNTN6', 'HES1', 'DLL3', 'DLK2']",0.9039432777481415,0,0,8
177,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.270266824596995,1.4249450817671467,1.8643205834030612,"['NFKBIA', 'ITK', 'ZAP70', 'GSK3A', 'CD8B', 'PTPN6', 'CALM1', 'CALM2']",0.9039432777481415,0,0,8
178,Effects of nitric oxide WP1995,0.2784487564852594,2.8491347794296855,3.642679316314195,"['AOX1', 'NOS1']",0.906301231528648,0,0,2
179,Nanomaterial-induced inflammasome activation WP3890,0.2784487564852594,2.8491347794296855,3.642679316314195,"['TLR4', 'CTSB']",0.906301231528648,0,0,2
180,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.2784487564852594,2.8491347794296855,3.642679316314195,"['CHRM1', 'CCKBR']",0.906301231528648,0,0,2
181,Steroid Biosynthesis WP496,0.2784487564852594,2.8491347794296855,3.642679316314195,"['HSD17B1', 'HSD3B1']",0.906301231528648,0,0,2
182,Wnt signaling WP428,0.2786263921253614,1.164525425368699,1.4881278157844107,"['TCF7', 'CXXC4', 'NKD1', 'WNT6', 'FRAT1', 'CCND3', 'FRAT2', 'PPP3R2', 'MYC', 'RAC1', 'WNT2', 'WNT4', 'FZD1', 'WNT10A', 'JUN', 'WNT5B', 'FZD5', 'SERPINF1', 'FZD9', 'NFATC3', 'WNT7A', 'NFATC1', 'DKK1', 'DKK2', 'SFRP4', 'SFRP2', 'PLCB4', 'ROR1', 'NOTUM']",0.906301231528648,0,0,29
183,Gastrin signaling pathway WP4659,0.2853077421927207,1.1558282208588957,1.4496245948827406,"['CDKN1B', 'SERPINE1', 'ELK1', 'FOXO1', 'EGFR', 'KAT5', 'CDH1', 'MYC', 'RAC1', 'JAK2', 'HRAS', 'MEF2D', 'MAPK3', 'CHGA', 'EGR1', 'JUN', 'SERPINB2', 'CDKN2A', 'BAD', 'PRKCD', 'RHOB', 'VEGFA', 'NFKBIA', 'CCKBR', 'KIT', 'PRKD2', 'PRKCQ', 'KRAS', 'LAMTOR3', 'CD44']",0.9114002690646759,0,0,30
184,Airway smooth muscle cell contraction WP4962,0.28789163904576753,1.5830623306233063,1.9711834999387459,"['RYR1', 'PPP1R14A', 'ITPR3', 'CALM1', 'CALM2']",0.9114002690646759,0,0,5
185,Galanin receptor pathway WP4970,0.28789163904576753,1.5830623306233063,1.9711834999387459,"['YAP1', 'CDKN1B', 'PRKCD', 'UCP1', 'VEGFA']",0.9114002690646759,0,0,5
186,Phytochemical activity on NRF2 transcriptional activation WP3,0.28789163904576753,1.5830623306233063,1.9711834999387459,"['AIMP2', 'CEBPB', 'MAF', 'KEAP1', 'HMOX1']",0.9114002690646759,0,0,5
187,Type II diabetes mellitus WP1584,0.28789163904576753,1.5830623306233063,1.9711834999387459,"['SURF1', 'KCNJ11', 'PRKCD', 'CACNA1A', 'PIK3R5']",0.9114002690646759,0,0,5
188,Differentiation of white and brown adipocyte WP2895,0.2920495153602812,1.4248413860419717,1.7537402559396338,"['PLAC8', 'CEBPA', 'CEBPB', 'LEP', 'ZIC1', 'EBF3', 'ZNF423']",0.9147794343560129,0,0,7
189,Purinergic signaling WP4900,0.2920495153602812,1.4248413860419717,1.7537402559396338,"['P2RY12', 'GNAZ', 'P2RY13', 'P2RY6', 'ADORA2A', 'LPAR6', 'P2RY14']",0.9147794343560129,0,0,7
190,CAMKK2  Pathway WP4874,0.30780372940049633,1.2953712953712955,1.526326853750263,"['FIS1', 'MAP1LC3A', 'MAF', 'WFS1', 'HMOX1', 'NOS1', 'RAC1', 'CALM1', 'CALM2', 'MAPK3']",0.924674414642713,0,0,10
191,Glucocorticoid Receptor Pathway WP2880,0.3086584826788597,1.1931308004392829,1.4025489364068682,"['SRGN', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'PLK2', 'AMIGO2', 'THBD', 'RGS2', 'NAV3', 'B3GNT5', 'ADGRF4', 'ENC1', 'BHLHE40', 'SPINK13', 'SPRY1', 'MFGE8']",0.924674414642713,0,0,18
192,Glycosylation and related congenital defects WP4521,0.3134872543380781,1.3410099211761835,1.5555669166172246,"['DPAGT1', 'GMPPB', 'DPM3', 'MPI', 'DOLK', 'MGAT2', 'ALG1', 'MPDU1']",0.924674414642713,0,0,8
193,Biogenic Amine Synthesis WP550,0.31413626971664294,1.628174312885359,1.8853092888066958,"['TPH1', 'PAH', 'GAD2', 'DBH']",0.924674414642713,0,0,4
194,Cells and molecules involved in local acute inflammatory response  WP4493,0.31413626971664294,1.628174312885359,1.8853092888066958,"['SELP', 'C3', 'SELPLG', 'C6']",0.924674414642713,0,0,4
195,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.31413626971664294,1.628174312885359,1.8853092888066958,"['TPO', 'ID2', 'FLT3LG', 'IKZF1']",0.924674414642713,0,0,4
196,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.31413626971664294,1.628174312885359,1.8853092888066958,"['IDI1', 'HMGCS1', 'IDI2', 'HMGCR']",0.924674414642713,0,0,4
197,Osteoblast Signaling WP322,0.31413626971664294,1.628174312885359,1.8853092888066958,"['COL1A1', 'BGLAP', 'PDGFB', 'TNFRSF11B']",0.924674414642713,0,0,4
198,Apoptosis Modulation by HSP70 WP384,0.31707585502106544,1.4247377409124176,1.6364740623827172,"['CASP7', 'CASP8', 'CASP6', 'CYCS', 'FADD', 'TNFRSF1A']",0.924674414642713,0,0,6
199,IL1 and megakaryocytes in obesity WP2865,0.31707585502106544,1.4247377409124176,1.6364740623827172,"['SELENBP1', 'IRAK1', 'F2R', 'IL18', 'TIMP2', 'S100A9']",0.924674414642713,0,0,6
200,Methionine De Novo and Salvage Pathway WP3580,0.31707585502106544,1.4247377409124176,1.6364740623827172,"['AHCY', 'CHDH', 'AMD1', 'ODC1', 'TXN', 'MAT2B']",0.924674414642713,0,0,6
201,Nucleotide metabolism WP404,0.31707585502106544,1.4247377409124176,1.6364740623827172,"['PRPS1', 'RRM2', 'RRM2B', 'POLD1', 'NME2', 'OAZ1']",0.924674414642713,0,0,6
202,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.31707585502106544,1.4247377409124176,1.6364740623827172,"['FGF7', 'TGFB1', 'SUV39H1', 'CDC37', 'FN1', 'IGFBP7']",0.924674414642713,0,0,6
203,Transcription factor regulation in adipogenesis WP3599,0.31707585502106544,1.4247377409124176,1.6364740623827172,"['CEBPA', 'CEBPB', 'CEBPD', 'LEP', 'FOXO1', 'PCK2']",0.924674414642713,0,0,6
204,TYROBP causal network in microglia WP3945,0.3264562934744984,1.2090546136011793,1.3534873141378851,"['RBM47', 'IGSF6', 'NCF2', 'IL18', 'TNFRSF1B', 'ZFP36L2', 'APBB1IP', 'C3', 'MAF', 'ADAP2', 'RGS1', 'CREB3L2', 'TMEM106A', 'C1QC']",0.9473633614554071,0,0,14
205,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.33120877915660873,1.073163582097507,1.1858525724920281,"['CHRM2', 'CDKN1B', 'CHRM1', 'CSF3R', 'ITGB4', 'LAMC3', 'TNC', 'SLC2A1', 'SLC2A3', 'HIF3A', 'FGF1', 'GYS2', 'GYS1', 'FGF7', 'FGF8', 'CREB3L1', 'CREB3L2', 'TNR', 'ITGB8', 'IKBKG', 'NOS1', 'JAK2', 'PELO', 'HRAS', 'HSP90AA1', 'HGF', 'F2R', 'NGF', 'PRLR', 'CREB3', 'CDC37', 'KIT', 'ITGA8', 'ATF4', 'LAMA4', 'LAMA3', 'PDGFB', 'LPAR2', 'THBS1', 'EGFR', 'FOXO1', 'THBS4', 'PIK3R5', 'PPP2CA', 'GNG10', 'GNG3', 'CHAD', 'GNG8', 'MAPK3', 'ANGPT2', 'ANGPT1', 'LAMB3', 'BAD', 'FN1', 'VEGFC', 'IGF1', 'GNG12', 'GNG11', 'VEGFA', 'COL1A1', 'EFNA1', 'FGF17', 'EFNA3', 'LPAR6', 'ITGA10', 'ITGA11', 'GNB4', 'KRAS', 'FGFR4', 'FGF10']",0.9546282246056343,0,0,70
206,Nephrotic syndrome WP4758,0.3362321570167893,1.2213186276220724,1.3311804078905576,"['CUBN', 'MYO1E', 'ITGB4', 'ARHGDIA', 'COL4A3', 'PDSS2', 'COL4A5', 'GPC5', 'EMP2', 'ALG1', 'ARHGAP24', 'PAX2']",0.9546282246056343,0,0,12
207,miRNA regulation of DNA damage response WP1530,0.34521580163554927,1.152117765905375,1.2253758025477135,"['CDKN1B', 'GADD45B', 'GADD45A', 'H2AFX', 'CDC25A', 'GADD45G', 'CCND3', 'CASP8', 'RAD51', 'RRM2B', 'CCNE2', 'MYC', 'SESN1', 'CHEK2', 'CCNG1', 'E2F1', 'CYCS', 'BAX', 'RAD9A']",0.9546282246056343,0,0,19
208,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.3461545390610362,1.7094588005850804,1.813513487612614,"['IRAK1', 'APOE', 'TLR4']",0.9546282246056343,0,0,3
209,Canonical NF-KB pathway WP4562,0.3461545390610362,1.7094588005850804,1.813513487612614,"['NFKBIA', 'IKBKG', 'NFKBIE']",0.9546282246056343,0,0,3
210,NAD Biosynthesis II (from tryptophan) WP2485,0.3461545390610362,1.7094588005850804,1.813513487612614,"['NMNAT1', 'HAAO', 'KMO']",0.9546282246056343,0,0,3
211,Vitamin D Metabolism WP1531,0.3461545390610362,1.7094588005850804,1.813513487612614,"['CYP27A1', 'CYP24A1', 'VDR']",0.9546282246056343,0,0,3
212,Cholesterol Biosynthesis Pathway WP197,0.34642793637142694,1.4246341463414633,1.5102268180827847,"['IDI1', 'HMGCS1', 'CYP51A1', 'MSMO1', 'HMGCR']",0.9546282246056343,0,0,5
213,ERK Pathway in Huntington's Disease WP3853,0.34642793637142694,1.4246341463414633,1.5102268180827847,"['CASP7', 'RPS6KA5', 'ELK1', 'HRAS', 'EGFR']",0.9546282246056343,0,0,5
214,Tryptophan catabolism leading to NAD+ production WP4210,0.34642793637142694,1.4246341463414633,1.5102268180827847,"['NMNAT1', 'HAAO', 'NMNAT3', 'KMO', 'IDO1']",0.9546282246056343,0,0,5
215,Pre-implantation embryo WP3527,0.3466977504902219,1.2389446302489782,1.3124164189790348,"['FOXQ1', 'EGR1', 'ARGFX', 'CDH1', 'DDIT3', 'HMGA1', 'FOSB', 'ATP1A1', 'AQP3', 'ZFP36L2']",0.9546282246056343,0,0,10
216,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.3579224131248905,1.2664008895397716,1.3011497131706524,"['CEBPA', 'CEBPB', 'PNCK', 'ERBB4', 'MYC', 'JAK2', 'PRLR', 'EGFR']",0.9688200859737158,0,0,8
217,Toll-like Receptor Signaling related to MyD88 WP3858,0.3579224131248905,1.2664008895397716,1.3011497131706524,"['TICAM2', 'IRAK1', 'IRF3', 'TOLLIP', 'TLR9', 'IKBKG', 'TLR4', 'RELB']",0.9688200859737158,0,0,8
218,Development of ureteric collection system WP5053,0.36003449140915117,1.205572883394085,1.2315595405443516,"['ROBO2', 'GRIP1', 'FRAS1', 'ITGA8', 'GFRA1', 'SPRY1', 'ETV4', 'FREM1', 'PAX2', 'FREM2', 'GLI2']",0.9688200859737158,0,0,11
219,IL-5 signaling pathway WP127,0.36003449140915117,1.205572883394085,1.2315595405443516,"['LYN', 'GSK3A', 'SPRED1', 'JUN', 'SYK', 'MYC', 'BCL2', 'KRAS', 'JAK2', 'ELK1', 'MAPK3']",0.9688200859737158,0,0,11
220,Lung fibrosis WP3624,0.36003449140915117,1.205572883394085,1.2315595405443516,"['DSP', 'FGF7', 'CEBPB', 'TGFB1', 'IL5', 'TERT', 'HGF', 'PDGFB', 'HMOX1', 'IGF1', 'FGF1']",0.9688200859737158,0,0,11
221,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.3687755494282083,1.1552567237163813,1.1524460847805094,"['CEBPA', 'CEBPB', 'NOTCH1', 'TGFB1', 'ICMT', 'MSTN', 'CEBPD', 'TCF7', 'TNFRSF11B', 'ACTB', 'KAT2B', 'E2F1', 'HES1', 'JUNB', 'EMD']",0.981905337684331,0,0,15
222,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.3698731255128476,1.3150299322536454,1.3079225060380986,"['LDHA', 'SLC2A1', 'KEAP1', 'PDHB', 'ACACB', 'VEGFA']",0.981905337684331,0,0,6
223,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3698731255128476,1.3150299322536454,1.3079225060380986,"['CASP7', 'CASP8', 'BAD', 'BCL2', 'BAX', 'FADD']",0.981905337684331,0,0,6
224,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.37319809651842284,1.2211565290178572,1.2036279388517588,"['TICAM2', 'IRAK1', 'SYK', 'IRF3', 'LY96', 'PLG', 'PLAT', 'IKBKG', 'TLR4']",0.985768212066765,0,0,9
225,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.3819145765413736,1.4245306022921238,1.3711937790602164,"['SST', 'DKK1', 'FOXO1', 'WNT4']",0.985768212066765,0,0,4
226,Cancer immunotherapy by CTLA4 blockade WP4582,0.3819145765413736,1.4245306022921238,1.3711937790602164,"['CD86', 'PPP2CA', 'CD80', 'PTPN6']",0.985768212066765,0,0,4
227,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.3819145765413736,1.4245306022921238,1.3711937790602164,"['ZEB1', 'IL6ST', 'JAK2', 'SOX4']",0.985768212066765,0,0,4
228,RalA downstream regulated genes WP2290,0.3819145765413736,1.4245306022921238,1.3711937790602164,"['EXOC8', 'KRAS', 'RAC1', 'HRAS']",0.985768212066765,0,0,4
229,Parkinson's disease pathway WP2371,0.3862847675555258,1.1872201872201873,1.129260622113693,"['CASP7', 'PINK1', 'UBA7', 'CCNE2', 'CASP6', 'SYT11', 'HTRA2', 'CYCS', 'UBE2L6', 'SNCAIP']",0.985768212066765,0,0,10
230,EV release from cardiac cells and their functional effects WP3297,0.3879797186006018,1.8992607035502478,1.7982242359944889,"['ERBB4', 'MYB']",0.985768212066765,0,0,2
231,let-7 inhibition of ES cell reprogramming WP3299,0.3879797186006018,1.8992607035502478,1.7982242359944889,"['EGR1', 'MYC']",0.985768212066765,0,0,2
232,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.3879797186006018,1.8992607035502478,1.7982242359944889,"['RAC1', 'VEGFA']",0.985768212066765,0,0,2
233,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.3879797186006018,1.8992607035502478,1.7982242359944889,"['EGFR', 'MAPK3']",0.985768212066765,0,0,2
234,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.39193563496719136,1.1397702273282817,1.0675745017411187,"['ITK', 'JUN', 'AHSA1', 'NFKBIA', 'ZAP70', 'IL5', 'CHP1', 'PRKCQ', 'PTPN6', 'IKBKG', 'CALM1', 'MAP3K14', 'CALM2', 'MAPK3']",0.9911878911153359,0,0,14
235,DNA damage response WP707,0.39386522150754494,1.11503069116286,1.0389259501255605,"['CDKN1B', 'GADD45B', 'GADD45A', 'H2AFX', 'CDC25A', 'GADD45G', 'CCND3', 'CASP8', 'RAD51', 'RRM2B', 'CCNE2', 'MYC', 'SESN1', 'CHEK2', 'E2F1', 'CYCS', 'BAX', 'RAD9A']",0.9911878911153359,0,0,18
236,Cell cycle WP179,0.3972935547634773,1.0773555084593556,0.9944851491726694,"['CDKN1B', 'YWHAB', 'CDC14A', 'ANAPC11', 'CCND3', 'PTTG1', 'PTTG2', 'MYC', 'CHEK2', 'E2F1', 'BUB3', 'YWHAG', 'SKP1', 'YWHAH', 'CDKN2D', 'CDKN2B', 'TGFB1', 'CDKN2C', 'GADD45B', 'GADD45A', 'CDKN2A', 'CDC25A', 'GADD45G', 'CCNA2', 'MAD2L2', 'RBL1', 'CCNE2', 'TFDP2', 'MCM3', 'MCM4', 'MCM2']",0.9911878911153359,0,0,31
237,Vitamin A and carotenoid metabolism WP716,0.3977107810281504,1.1608225225714235,1.070313444349118,"['ALDH1A3', 'CYP26B1', 'RBP4', 'RDH12', 'RBP2', 'NPC1L1', 'ALDH1A2', 'ALDH1A1', 'LPL', 'LRAT', 'BCO1']",0.9911878911153359,0,0,11
238,IL17 signaling pathway WP2112,0.4029322001109413,1.199645440180877,1.0904620726972263,"['CEBPB', 'TRAF3IP2', 'CEBPD', 'IKBKG', 'IL17RE', 'JAK2', 'MAP3K14', 'MAPK3']",0.9911878911153359,0,0,8
239,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4055131762345129,1.295011086474501,1.1688794829176965,"['MLPH', 'RAB27A', 'SYTL5', 'SYTL4', 'SYTL3']",0.9911878911153359,0,0,5
240,MAPK pathway in congenital thyroid cancer WP4928,0.4055131762345129,1.295011086474501,1.1688794829176965,"['JUN', 'MYC', 'KRAS', 'ELK1', 'MAPK3']",0.9911878911153359,0,0,5
241,Serotonin and anxiety WP3947,0.4055131762345129,1.295011086474501,1.1688794829176965,"['GABRA1', 'ARC', 'CRH', 'TRPV1', 'ADRA1A']",0.9911878911153359,0,0,5
242,Small cell lung cancer WP4658,0.4119678890418156,1.0793597742127155,0.9571869030916357,"['CDKN1B', 'LAMC3', 'LAMA4', 'LAMA3', 'FHIT', 'CKS1B', 'CASP8', 'MYC', 'E2F1', 'IKBKG', 'SKP1', 'CDKN2B', 'LAMB3', 'GADD45B', 'GADD45A', 'FN1', 'GADD45G', 'NFKBIA', 'CCNE2', 'COL4A3', 'CKS2', 'BCL2', 'COL4A5', 'CYCS', 'BAX']",0.9911878911153359,0,0,25
243,Wnt signaling in kidney disease WP4150,0.41539944029069253,1.1655495383522727,1.0239524204333683,"['FZD1', 'WNT6', 'WNT10A', 'FZD5', 'WNT5B', 'FZD9', 'WNT7A', 'WNT2', 'WNT4']",0.9911878911153359,0,0,9
244,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.41692867805447625,1.1224192067300571,0.9819373396466398,"['PPP1R15A', 'PPP1R14A', 'XBP1', 'PPP1R11', 'HSPA5', 'PPP1CC', 'PPP1R3F', 'MAP1LC3A', 'PPP1R1A', 'PPP1R1C', 'DDIT3', 'BCL2', 'ATF4']",0.9911878911153359,0,0,13
245,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4229115670825093,1.2209946676889833,1.0507784665745934,"['H3F3B', 'H2AFZ', 'H2AFX', 'DUSP6', 'HIST1H3E', 'MAPK3']",0.9911878911153359,0,0,6
246,One-carbon metabolism WP241,0.4229115670825093,1.2209946676889833,1.0507784665745934,"['ALDH1L1', 'AHCY', 'TCN2', 'CHDH', 'GLRX', 'MAT2B']",0.9911878911153359,0,0,6
247,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.4229115670825093,1.2209946676889833,1.0507784665745934,"['EGLN2', 'SELE', 'BCL2L2', 'RELB', 'VEGFA', 'TNFRSF1A']",0.9911878911153359,0,0,6
248,"Relationship between inflammation, COX-2 and EGFR WP4483",0.4229115670825093,1.2209946676889833,1.0507784665745934,"['PTGES2', 'PTGER3', 'KRAS', 'HRAS', 'EGFR', 'MAPK3']",0.9911878911153359,0,0,6
249,VEGFA-VEGFR2 Signaling Pathway WP3888,0.42536834288989483,1.027627655213123,0.8784159103106142,"['TRAF3IP2', 'NCF2', 'ARPC5L', 'RPL10A', 'ELK1', 'RPL7', 'ACTG1', 'TUBB8', 'RPS6KA5', 'RPL18A', 'CFL1', 'CHAC1', 'ATP6V1E1', 'IER5', 'TMSB10', 'IGFBP3', 'PRKCD', 'DKK1', 'INPP4B', 'RAB37', 'KATNAL2', 'FSCN1', 'TXNIP', 'PRKD2', 'RPL27', 'RPL26', 'ERG', 'ATP6V0D1', 'DSC1', 'ATF4', 'LRRC59', 'SET', 'FOXO4', 'TXN', 'ACACB', 'FUT1', 'FOXO1', 'STIP1', 'LDHA', 'PGK1', 'IGFBP7', 'FADD', 'EGR1', 'JUN', 'SDF2L1', 'EGR3', 'FN1', 'NFATC1', 'BMX', 'SELE', 'NFKBIA', 'NR4A1', 'NR4A3', 'ALB', 'BCL2', 'CYCS', 'HYOU1', 'CALR', 'EIF4G2', 'ARF4', 'HSPB1', 'NRARP', 'SHB', 'HERPUD1', 'RND1', 'TUBA1C', 'CSRP2', 'ADAMTS1', 'TMSB4X', 'RACK1', 'RPLP2', 'SH3BGRL3', 'ELOC', 'RAC1', 'CLIC1', 'HRAS', 'CGNL1', 'PRKG1', 'DUSP5', 'HSP90AA1', 'SSR4', 'GAB1', 'RPL13A', 'EPN1', 'VAV2', 'RCN1', 'TKT', 'ALDOA', 'GAPDH', 'SLC25A11', 'FJX1', 'ARF6', 'APOLD1', 'PPP2CA', 'DNAJB4', 'DNAJB9', 'CCT7', 'ABCF2', 'SLC25A25', 'MAPK3', 'SOD2', 'RAB11A', 'VEGFA', 'DNAJA1', 'FMNL3', 'PTPN6']",0.9911878911153359,0,0,106
250,Small Ligand GPCRs WP247,0.4269474868824504,1.42442710872745,1.21232172869949,"['PTGER3', 'S1PR2', 'PTGDR']",0.9911878911153359,0,0,3
251,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4269474868824504,1.42442710872745,1.21232172869949,"['NOTCH1', 'TBX6', 'DLL3']",0.9911878911153359,0,0,3
252,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.4269474868824504,1.42442710872745,1.21232172869949,"['MYOCD', 'ELK1', 'MEF2D']",0.9911878911153359,0,0,3
253,Supression of HMGB1 mediated inflammation by THBD WP4479,0.4269474868824504,1.42442710872745,1.21232172869949,"['NFKBIA', 'THBD', 'IKBKG']",0.9911878911153359,0,0,3
254,Trans-sulfuration pathway WP2333,0.4269474868824504,1.42442710872745,1.21232172869949,"['AHCY', 'GOT1', 'MAT2B']",0.9911878911153359,0,0,3
255,Vitamin B12 Disorders WP4271,0.4269474868824504,1.42442710872745,1.21232172869949,"['CUBN', 'TCN2', 'TCN1']",0.9911878911153359,0,0,3
256,Glycogen Synthesis and Degradation WP500,0.43555937822199714,1.1192686160932375,0.9302511738616698,"['PPP2CA', 'GYS2', 'GYS1', 'GSK3A', 'PHKG1', 'GBE1', 'PHKA1', 'CALM3', 'CALM1', 'GYG1', 'CALM2']",0.9999956133475378,0,0,11
257,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.44880692103901704,1.2661410496084966,1.01438473331969,"['RYR1', 'CCKBR', 'CCK', 'RYR3']",0.9999956133475378,0,0,4
258,FOXA2 pathway WP5066,0.44880692103901704,1.2661410496084966,1.01438473331969,"['ABCC3', 'ABCC2', 'FASN', 'FOXO1']",0.9999956133475378,0,0,4
259,Glutathione metabolism WP100,0.44880692103901704,1.2661410496084966,1.01438473331969,"['GPX2', 'GPX4', 'GPX3', 'GGT2']",0.9999956133475378,0,0,4
260,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.44880692103901704,1.2661410496084966,1.01438473331969,"['CSRP2', 'CDH1', 'E2F1', 'SOX4']",0.9999956133475378,0,0,4
261,Homologous recombination WP186,0.44880692103901704,1.2661410496084966,1.01438473331969,"['POLD4', 'RAD51', 'POLD1', 'POLD2']",0.9999956133475378,0,0,4
262,Major receptors targeted by epinephrine and norepinephrine WP4589,0.44880692103901704,1.2661410496084966,1.01438473331969,"['ADCY10', 'ADRB1', 'ADRA1D', 'ADRA2C']",0.9999956133475378,0,0,4
263,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.44880692103901704,1.2661410496084966,1.01438473331969,"['PTTG1', 'BUB1B', 'BUB3', 'ANAPC11']",0.9999956133475378,0,0,4
264,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.4522037661242251,2.848684210526316,2.26077957357806,['FMO5'],0.9999956133475378,0,0,1
265,"COVID-19, thrombosis and anticoagulation WP4927",0.4522037661242251,2.848684210526316,2.26077957357806,['PLG'],0.9999956133475378,0,0,1
266,Melatonin metabolism and effects WP3298,0.45750209442970907,1.114777938179348,0.8717271586324471,"['PER2', 'IRAK1', 'CYP1B1', 'ADRB1', 'APOE', 'CYP2C19', 'CALM1', 'CALM2', 'FOXO1']",0.9999956133475378,0,0,9
267,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.4584138112270913,1.0779760449767783,0.8408029731378766,"['VAV3', 'BEX3', 'CDKN1B', 'HSPA5', 'F2R', 'HSPB1', 'NRG1', 'RNF7', 'THBS1', 'CASP7', 'APOE', 'VIM', 'CARD14', 'IER3']",0.9999956133475378,0,0,14
268,Translation Factors WP107,0.4584138112270913,1.0779760449767783,0.8408029731378766,"['EIF4A2', 'EIF2B2', 'EIF1AX', 'EEF2', 'GSPT2', 'EIF1', 'EEF1B2', 'EEF1G', 'EIF5', 'EIF6', 'EIF3I', 'EEF1A2', 'EIF4H', 'EIF3CL']",0.9999956133475378,0,0,14
269,GDNF/RET signaling axis WP4830,0.46382588863405416,1.1869918699186992,0.9119018002404194,"['ROBO2', 'EYA1', 'GFRA1', 'SPRY1', 'PAX2']",0.9999956133475378,0,0,5
270,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.46382588863405416,1.1869918699186992,0.9119018002404194,"['EIF5', 'EIF1AX', 'EIF3I', 'EIF3CL', 'EIF1']",0.9999956133475378,0,0,5
271,Proteoglycan biosynthesis WP4784,0.46382588863405416,1.1869918699186992,0.9119018002404194,"['SLC35B2', 'B3GAT3', 'XYLT1', 'B3GALT6', 'B4GALT7']",0.9999956133475378,0,0,5
272,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4658459485714768,1.0957077110923266,0.8370114294662255,"['PLCB4', 'STAR', 'FSHR', 'PRKCD', 'HSD3B1', 'PRKCQ', 'KRAS', 'AMH', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,10
273,Proteasome Degradation WP183,0.4706011738752758,1.0600419730758075,0.7990006037325391,"['UBA7', 'H2AFZ', 'H2AFX', 'HLA-C', 'HLA-F', 'PSMB10', 'HLA-E', 'PSMB9', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMD2', 'NEDD4', 'PSMD3', 'UBC']",0.9999956133475378,0,0,16
274,Neural Crest Differentiation WP2064,0.472740309992258,1.044591395215936,0.7826173464460087,"['NOTCH3', 'NOTCH1', 'MIA', 'WNT8A', 'MITF', 'TBX6', 'CDH7', 'GFAP', 'RHOB', 'DLL3', 'CDH6', 'PRTG', 'FGF8', 'GJB1', 'CDH1', 'PAX7', 'MYC', 'MYB', 'HEY2', 'ZIC1', 'HES1', 'SOX5']",0.9999956133475378,0,0,22
275,NO/cGMP/PKG mediated Neuroprotection WP4008,0.473235206629559,1.0805804962687195,0.8084500740467906,"['NFKBIA', 'BAD', 'NPPA', 'CNGA1', 'BCL2', 'PDE3A', 'NEFL', 'CYCS', 'NOS1', 'CALM1', 'CALM2']",0.9999956133475378,0,0,11
276,Eicosanoid Synthesis WP167,0.4752563656440847,1.1394974383996097,0.8476731738440012,"['PTGES2', 'ALOX15', 'TBXAS1', 'ALOX12', 'GGT2', 'PTGES']",0.9999956133475378,0,0,6
277,Statin inhibition of cholesterol production WP430,0.4752563656440847,1.1394974383996097,0.8476731738440012,"['ABCA1', 'APOC2', 'LPL', 'APOA1', 'HMGCR', 'APOE']",0.9999956133475378,0,0,6
278,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.4811536937836546,1.046493860573346,0.7655819754632366,"['DSP', 'JUP', 'ITGB4', 'TCF7', 'ATP2A2', 'ACTB', 'ACTG1', 'ITGA10', 'ITGA11', 'PKP2', 'ITGA8', 'ITGB8', 'DMD', 'CTNNA2', 'CACNG2', 'EMD', 'CACNG4', 'CACNG5']",0.9999956133475378,0,0,18
279,Cell migration and invasion through p75NTR WP4561,0.4845052238625457,1.1078303779621494,0.8027638761241169,"['EFNA1', 'ARF1', 'JUN', 'EFNA3', 'EFNB3', 'CDH11', 'RAC1']",0.9999956133475378,0,0,7
280,Synaptic Vesicle Pathway WP2267,0.4859048299599896,1.058099427454266,0.7636753232525746,"['NSF', 'RAB3A', 'CACNA1A', 'SYN3', 'CPLX1', 'DNM2', 'CPLX3', 'CLTCL1', 'SLC17A6', 'SLC17A8', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.9999956133475378,0,0,13
281,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.48932117203306835,1.424323665610529,1.0180157008194715,"['GSTP1', 'COX5A']",0.9999956133475378,0,0,2
282,FTO Obesity Variant Mechanism WP3407,0.48932117203306835,1.424323665610529,1.0180157008194715,"['TBX1', 'UCP1']",0.9999956133475378,0,0,2
283,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.48932117203306835,1.424323665610529,1.0180157008194715,"['WNT6', 'ABCB1']",0.9999956133475378,0,0,2
284,Metabolism of alpha-linolenic acid WP4586,0.48932117203306835,1.424323665610529,1.0180157008194715,"['ALOX15', 'ALOX12']",0.9999956133475378,0,0,2
285,Peroxiredoxin 2 induced ovarian failure WP4873,0.48932117203306835,1.424323665610529,1.0180157008194715,"['STAR', 'BAX']",0.9999956133475378,0,0,2
286,Somatic sex determination WP4814,0.48932117203306835,1.424323665610529,1.0180157008194715,"['AMH', 'WNT4']",0.9999956133475378,0,0,2
287,Type 2 papillary renal cell carcinoma WP4241,0.49905370549989353,1.0682373046875,0.7424693256588027,"['TGFB1', 'EGLN2', 'PDGFB', 'SLC2A1', 'TFEB', 'COL21A1', 'ELOB', 'ELOC', 'VEGFA']",0.9999956133475378,0,0,9
288,p53 transcriptional gene network WP4963,0.5013191745222473,1.03586117966162,0.7152748917072275,"['BTG2', 'NOTCH1', 'NCF2', 'MGMT', 'GADD45A', 'SERPINE1', 'SLC2A1', 'ISG15', 'THBS1', 'DRAM1', 'RRM2B', 'ZMAT3', 'SESN1', 'CCNG1', 'BAX', 'RPRM']",0.9999956133475378,0,0,16
289,Dopamine metabolism WP2436,0.5038351516603505,1.2208330431148569,0.8368885524053876,"['PPP2CA', 'TYR', 'SOD1']",0.9999956133475378,0,0,3
290,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5038351516603505,1.2208330431148569,0.8368885524053876,"['MAFF', 'PRKCQ', 'MAFK']",0.9999956133475378,0,0,3
291,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5038351516603505,1.2208330431148569,0.8368885524053876,"['MYC', 'FN1', 'VIM']",0.9999956133475378,0,0,3
292,Neuroinflammation WP4919,0.5038351516603505,1.2208330431148569,0.8368885524053876,"['NFKBIA', 'JUN', 'TLR4']",0.9999956133475378,0,0,3
293,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5038351516603505,1.2208330431148569,0.8368885524053876,"['TGFB1', 'IL5', 'IL12RB2']",0.9999956133475378,0,0,3
294,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5104176802407802,1.0444715844325028,0.7024342002633748,"['CASP7', 'JUN', 'TGFB1', 'RRM2', 'MYC', 'MYOF', 'RAC1', 'CD44', 'VAV2', 'MAPK3', 'VEGFA']",0.9999956133475378,0,0,11
295,IL-6 signaling pathway WP364,0.5104176802407802,1.0444715844325028,0.7024342002633748,"['HCK', 'BAD', 'PRKCD', 'GAB1', 'RAC1', 'JAK2', 'IL6ST', 'JUNB', 'AGT', 'MAPK3', 'NR2F6']",0.9999956133475378,0,0,11
296,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5131730004329882,1.1394294074615947,0.760161507553168,"['YAP1', 'COL1A1', 'EDNRA', 'FN1']",0.9999956133475378,0,0,4
297,Osteoblast differentiation WP4787,0.5167233858688448,1.0119511628507267,0.6681383110673346,"['NOTCH3', 'NOTCH1', 'WNT8A', 'FGF1', 'PIK3R5', 'GLI2', 'DLL3', 'WNT6', 'FGF7', 'FGF8', 'HEY1', 'HEY2', 'WNT2', 'WNT4', 'MAPK3', 'FZD1', 'WNT10A', 'WNT5B', 'FZD5', 'PTCH1', 'PRKCD', 'FZD9', 'WNT7A', 'WNT9A', 'PRKCQ', 'FGFR4', 'FGF10']",0.9999956133475378,0,0,27
298,Corticotropin-releasing hormone signaling pathway WP2355,0.521291874741357,1.0138490014774482,0.6604670390358829,"['GNAZ', 'HSP90AA1', 'TGFB1', 'JUP', 'PRKCD', 'HSD3B1', 'IL18', 'ELK1', 'TBX19', 'FOSL2', 'NFKBIA', 'CRHBP', 'NR4A1', 'STAR', 'CRH', 'BCL2', 'FOSB', 'PRKCQ', 'JUNB', 'TLR4', 'MAPK3']",0.9999956133475378,0,0,21
299,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.5261082686258431,1.0681873627714076,0.6860414681890341,"['HPGD', 'TRPA1', 'ACOX2', 'ALOX15', 'ALOX12', 'TRPV1']",0.9999956133475378,0,0,6
300,PKC-gamma calcium signaling pathway in ataxia WP4760,0.5261082686258431,1.0681873627714076,0.6860414681890341,"['GRIA1', 'GNA15', 'PLCB4', 'CACNA1A', 'CA8', 'RYR3']",0.9999956133475378,0,0,6
301,Acute viral myocarditis WP4298,0.535117144780752,1.0087858773646445,0.6307631358192309,"['ENDOG', 'TGFB1', 'CD80', 'AIF1', 'ACTB', 'CASP7', 'CASP8', 'CASP6', 'BCL2', 'CYCS', 'BAX', 'DMD', 'NOS1', 'TLR4', 'MICA', 'EIF4G2', 'MAPK3']",0.9999956133475378,0,0,17
302,Fluoropyrimidine Activity WP1601,0.5356068985703799,1.0357911553908625,0.6467011643039512,"['ABCC3', 'CYP2A6', 'RRM2', 'DPYS', 'UPP2', 'TK1', 'UPB1', 'TYMP']",0.9999956133475378,0,0,8
303,p38 MAPK Signaling Pathway WP400,0.5396505030072083,1.025419921875,0.6325134266599888,"['RPS6KA5', 'MYC', 'DDIT3', 'HSPB1', 'RAC1', 'ELK1', 'HRAS', 'MEF2D', 'HMGN1']",0.9999956133475378,0,0,9
304,ATM Signaling Pathway WP2516,0.5433655482219634,1.0172684458398744,0.6205062698459409,"['NFKBIA', 'JUN', 'RAD51', 'CRADD', 'GADD45A', 'CHEK2', 'H2AFX', 'IKBKG', 'CDC25A', 'RAD9A']",0.9999956133475378,0,0,10
305,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.5433655482219634,1.0172684458398744,0.6205062698459409,"['LYN', 'NFKBIA', 'HCK', 'CISH', 'FES', 'MYC', 'TNFSF4', 'JAK2', 'RELB', 'MAPK3']",0.9999956133475378,0,0,10
306,22q11.2 copy number variation syndrome WP4657,0.5579850962844113,0.9889025054466231,0.5769484922705044,"['RTL10', 'OAT', 'LRRC74B', 'RTN4', 'EGFR', 'CYP26B1', 'FGF8', 'MRPL40', 'CLTCL1', 'RCC1', 'DGCR6L', 'HES1', 'TBX1', 'RANBP1', 'SERPIND1', 'GP1BA', 'SLC7A4', 'ACTA2', 'CLDN5', 'ACTC1', 'THAP7', 'ALDH1A2', 'BCL2', 'RAN', 'FGF10']",0.9999956133475378,0,0,25
307,Oncostatin M Signaling Pathway WP2374,0.5587507130013244,0.9935463694774549,0.5782955093601867,"['EGR1', 'CEBPB', 'CDKN1B', 'SERPINE1', 'PRKCD', 'VEGFA', 'NFKBIA', 'CASP7', 'TIMP3', 'KRAS', 'JAK2', 'IL6ST', 'JUNB', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,15
308,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5738075305123583,1.0357562457050387,0.5753224605801158,"['ABCA1', 'HMGCS1', 'FASN', 'HMGCR']",0.9999956133475378,0,0,4
309,Ebstein-Barr virus LMP1 signaling WP262,0.5739806664942266,1.017247386759582,0.5647346170315665,"['NFKBIA', 'HSP90AA1', 'IRAK1', 'IKBKG', 'MAP3K14']",0.9999956133475378,0,0,5
310,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5739806664942266,1.017247386759582,0.5647346170315665,"['HTR2B', 'KRAS', 'ELK1', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,5
311,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5739806664942266,1.017247386759582,0.5647346170315665,"['EGR1', 'HTR7', 'RPS6KA5', 'ELK1', 'MAPK3']",0.9999956133475378,0,0,5
312,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5748168696874931,1.005266707805347,0.5566199724137965,"['CASP8', 'ZMAT3', 'EI24', 'CHEK2', 'SERPINE1', 'BAX']",0.9999956133475378,0,0,6
313,TLR4 Signaling and Tolerance WP3851,0.5748168696874931,1.005266707805347,0.5566199724137965,"['NFKBIA', 'IRAK1', 'IRF3', 'INPP5D', 'IKBKG', 'TLR4']",0.9999956133475378,0,0,6
314,Alanine and aspartate metabolism WP106,0.5749721850610174,1.068137493905412,0.5911431926056229,"['GOT1', 'GAD2', 'ASS1']",0.9999956133475378,0,0,3
315,Sulfation Biotransformation Reaction WP692,0.5749721850610174,1.068137493905412,0.5911431926056229,"['SULT1C2', 'SULT4A1', 'SULT1C4']",0.9999956133475378,0,0,3
316,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5760140165838156,0.9968765251342118,0.5499003027717263,"['TGFB1', 'HGF', 'KRAS', 'MFGE8', 'HRAS', 'EGFR', 'PIK3R5']",0.9999956133475378,0,0,7
317,Type II interferon signaling (IFNG) WP619,0.5760140165838156,0.9968765251342118,0.5499003027717263,"['CIITA', 'OAS1', 'PRKCD', 'TAP1', 'ISG15', 'JAK2', 'PSMB9']",0.9999956133475378,0,0,7
318,B Cell Receptor Signaling Pathway WP23,0.5774161822635538,0.9776265658478797,0.5369046753205042,"['LYN', 'MAP4K1', 'JUN', 'GSK3A', 'SYK', 'CD81', 'PRKCD', 'NFATC3', 'GAB1', 'ELK1', 'ILF2', 'FOXO1', 'RASGRP3', 'VAV2', 'NFKBIA', 'MYC', 'INPP5D', 'BLNK', 'PTPN6', 'RAC1', 'IKBKG', 'HRAS', 'MEF2D']",0.9999956133475378,0,0,23
319,Neovascularisation processes WP4331,0.5774181642372206,0.9906718595791194,0.5440656456308043,"['NOTCH3', 'NOTCH1', 'TGFB1', 'ANGPT1', 'KIT', 'PDGFB', 'RELB', 'MAPK3']",0.9999956133475378,0,0,8
320,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.5793328577888653,1.1393614428466976,0.6219524398927034,"['CYP51A1', 'DHCR24']",0.9999956133475378,0,0,2
321,Ketogenesis and Ketolysis WP4742,0.5793328577888653,1.1393614428466976,0.6219524398927034,"['CPT2', 'SLC2A1']",0.9999956133475378,0,0,2
322,Mevalonate pathway WP3963,0.5793328577888653,1.1393614428466976,0.6219524398927034,"['HMGCS1', 'HMGCR']",0.9999956133475378,0,0,2
323,Tgif disruption of Shh signaling WP3674,0.5793328577888653,1.1393614428466976,0.6219524398927034,"['FGF8', 'NODAL']",0.9999956133475378,0,0,2
324,Netrin-UNC5B signaling pathway WP4747,0.5821758566734053,0.97902418172936,0.5296351624857802,"['YAP1', 'COL1A1', 'DCSTAMP', 'JUN', 'ITGB4', 'INPP5D', 'ALPL', 'RAC1', 'NTN1', 'SELE', 'MAPK3']",0.9999956133475378,0,0,11
325,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5821758566734053,0.97902418172936,0.5296351624857802,"['CCNA2', 'FGF7', 'HSP90AA1', 'JUN', 'CDKN2A', 'BCL2', 'BAX', 'ELK1', 'JUNB', 'EGFR', 'TNFRSF1A']",0.9999956133475378,0,0,11
326,Cardiac Hypertrophic Response WP2795,0.5854924263982905,0.9743144518186962,0.5215525051834424,"['MAP4K1', 'TGFB1', 'NRG1', 'IGF1', 'TNFRSF1A', 'NPPA', 'RAC1', 'IKBKG', 'CALM1', 'MAP3K14', 'CALM2', 'PRKG1', 'MAPK3']",0.9999956133475378,0,0,13
327,Phosphodiesterases in neuronal function WP4222,0.5854924263982905,0.9743144518186962,0.5215525051834424,"['GRIA1', 'PDE6H', 'ADCY10', 'PDE10A', 'ADORA2A', 'PDE3A', 'PDE6C', 'PDE5A', 'PDE6B', 'CHRFAM7A', 'NOS1', 'PDE6A', 'PDE9A']",0.9999956133475378,0,0,13
328,T-cell receptor (TCR) signaling pathway WP69,0.5952563790204618,0.9662086567372911,0.5012333759211367,"['MAP4K1', 'VAV3', 'ITK', 'JUN', 'CD83', 'TGFB1', 'FYB1', 'PRKCD', 'NFATC1', 'NFKBIA', 'ZAP70', 'PSTPIP1', 'PRKCQ', 'IKBKG', 'CD247', 'VIM', 'HRAS', 'MAP3K14', 'MAPK3']",0.9999956133475378,0,0,19
329,DNA damage response (only ATM dependent) WP710,0.6043866889903752,0.9620098039215687,0.4844114482647704,"['CDKN1B', 'TCF7', 'PIK3R5', 'WNT6', 'FRAT1', 'CCND3', 'MYC', 'RAC1', 'WNT2', 'HRAS', 'WNT4', 'PCK2', 'WNT10A', 'JUN', 'TGFB1', 'WNT5B', 'BIK', 'CDKN2A', 'BAD', 'WNT7A', 'SOD2', 'CCNG2', 'BCL2', 'BAX', 'KRAS']",0.9999956133475378,0,0,25
330,Regulation of toll-like receptor signaling pathway WP1449,0.605842858983908,0.9614974385751537,0.4818396680746782,"['CD86', 'CUEDC2', 'CD80', 'PELI3', 'PELI2', 'LY96', 'PIK3R5', 'CASP8', 'IRAK1', 'TIFA', 'FADD', 'RAC1', 'IKBKG', 'TMED7', 'MAPK3', 'JUN', 'TICAM2', 'FBXW5', 'CISH', 'SYK', 'NFKBIA', 'IRF3', 'TOLLIP', 'TLR9', 'PTPN6', 'TLR4']",0.9999956133475378,0,0,26
331,Copper homeostasis WP3286,0.6163083338017242,0.9492877492877493,0.4594627688817547,"['PRNP', 'JUN', 'STEAP4', 'SCO2', 'COX17', 'STEAP1', 'STEAP2', 'FOXO1', 'ATOX1', 'SOD1']",0.9999956133475378,0,0,10
332,IL-4 signaling pathway WP395,0.6164730742710511,0.949262969297174,0.4591970691575255,"['NFKBIA', 'CEBPA', 'CEBPB', 'HRH1', 'NFIL3', 'BAD', 'FES', 'INPP5D', 'PTPN6', 'JAK2', 'ELK1', 'MAPK3']",0.9999956133475378,0,0,12
333,Alpha 6 Beta 4 signaling pathway WP244,0.6173901612637439,0.9493125050850215,0.4578098504145719,"['LAMB3', 'ITGB4', 'LAMA3', 'PRKCD', 'GAB1', 'RAC1', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,8
334,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.6187155573135662,0.9493248739222385,0.4557800154840664,"['FZD1', 'EDA', 'CDH1', 'MYC', 'PTCH1', 'FGF1', 'GLI2']",0.9999956133475378,0,0,7
335,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6187155573135662,0.9493248739222385,0.4557800154840664,"['CDKN1B', 'BAD', 'TFEB', 'KRAS', 'FOXO4', 'HRAS', 'FOXO1']",0.9999956133475378,0,0,7
336,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6187155573135662,0.9493248739222385,0.4557800154840664,"['ACTA2', 'CASP8', 'TGFB1', 'BAX', 'PRKCQ', 'NOS1', 'TNFRSF1A']",0.9999956133475378,0,0,7
337,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6187155573135662,0.9493248739222385,0.4557800154840664,"['FZD1', 'COL1A1', 'ADAMTS2', 'CREB3L1', 'SERPINF1', 'PLOD2', 'TNFRSF11B']",0.9999956133475378,0,0,7
338,Gastric Cancer Network 1 WP2361,0.6208823915780362,0.9493372367244043,0.4524670385095519,"['SMOC2', 'NOTCH1', 'MCM4', 'GATD3B', 'LIN9', 'GATD3A']",0.9999956133475378,0,0,6
339,Physiological and pathological hypertrophy of the heart WP1528,0.6208823915780362,0.9493372367244043,0.4524670385095519,"['JUN', 'RAC1', 'IL6ST', 'CALM1', 'CALM2', 'AGT']",0.9999956133475378,0,0,6
340,Androgen receptor signaling pathway WP138,0.6229300579974385,0.9491511589944499,0.4492532070045441,"['JUN', 'LIMK2', 'NCOA4', 'DSTN', 'RNF6', 'ETV5', 'FOXO1', 'EGFR', 'RHOB', 'KAT2B', 'AR', 'SUMO1', 'KAT5', 'BAG1', 'RACK1', 'STUB1', 'RAC1', 'CALR', 'FKBP4', 'RAN', 'RAD9A']",0.9999956133475378,0,0,21
341,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6243369962228464,0.949349593495935,0.4472053646862746,"['B3GALNT1', 'B3GALT1', 'B4GALNT1', 'SGMS2', 'ST6GALNAC3']",0.9999956133475378,0,0,5
342,Vitamin D in inflammatory diseases WP4482,0.6243369962228464,0.949349593495935,0.4472053646862746,"['NFKBIA', 'VDR', 'DUSP1', 'NFATC1', 'IKBKG']",0.9999956133475378,0,0,5
343,Male infertility WP4673,0.62682486571661,0.9491013071895424,0.4433139247572274,"['ABCB1', 'PON1', 'CLU', 'THBS1', 'CYP26B1', 'DND1', 'NOS1', 'RGS9', 'RAG1', 'SOX5', 'PACRG', 'CCDC36', 'HMGA1', 'PEX10', 'TEX15', 'SOD2', 'ETV5', 'AR', 'SPATA17', 'TCN2', 'MSH4', 'MSH5', 'BCL2', 'HLA-DRA', 'BRDT']",0.9999956133475378,0,0,25
344,NAD+ metabolism WP3644,0.6299056055163249,0.949361944241242,0.438781138175117,"['NT5E', 'NMNAT1', 'NRK', 'NMNAT3']",0.9999956133475378,0,0,4
345,Iron metabolism in placenta WP2007,0.6393246684146128,0.9493742889647326,0.42469581471697393,"['TF', 'HEPHL1', 'FTH1']",0.9999956133475378,0,0,3
346,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.6393246684146128,0.9493742889647326,0.42469581471697393,"['NFKBIA', 'IKBKG', 'MAP3K14']",0.9999956133475378,0,0,3
347,3q29 copy number variation syndrome WP4906,0.6464570480903123,0.9270832741184563,0.40443870678798266,"['GRIA1', 'TM4SF19', 'JUN', 'TGFB1', 'NCBP2', 'DYNLT3', 'MAD2L1BP', 'FBXO45', 'SLC51A', 'DYNLL1', 'DYNLL2', 'CASP7', 'TF', 'MYC']",0.9999956133475378,0,0,14
348,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6525168045012313,0.9153180803571429,0.3907661176269377,"['NFKBIA', 'CASP7', 'JUN', 'CASP8', 'FADD', 'RAC1', 'MAP3K14', 'RELB', 'MAPK3']",0.9999956133475378,0,0,9
349,Vitamin D-sensitive calcium signaling in depression WP4698,0.6525168045012313,0.9153180803571429,0.3907661176269377,"['CYP27A1', 'TPH1', 'CHRM1', 'CALB1', 'GPX4', 'VDR', 'BCL2', 'ITPR3', 'GGT2']",0.9999956133475378,0,0,9
350,Estrogen metabolism WP697,0.6570588936154153,0.94938662767081,0.39872493798629594,"['CYP1B1', 'CYP3A4']",0.9999956133475378,0,0,2
351,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.6570588936154153,0.94938662767081,0.39872493798629594,"['ELOB', 'ELOC']",0.9999956133475378,0,0,2
352,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.6570588936154153,0.94938662767081,0.39872493798629594,"['IRAK1', 'TIFA']",0.9999956133475378,0,0,2
353,Liver X receptor pathway WP2874,0.6570588936154153,0.94938662767081,0.39872493798629594,"['FASN', 'CYP3A4']",0.9999956133475378,0,0,2
354,Angiogenesis WP1539,0.6709246535269853,0.8899390243902439,0.35517327467494736,"['ANGPT1', 'PDGFB', 'TIMP2', 'TIMP3', 'VEGFA']",0.9999956133475378,0,0,5
355,IL-7 signaling pathway WP205,0.6709246535269853,0.8899390243902439,0.35517327467494736,"['CDKN1B', 'BAD', 'IL7', 'MYC', 'MAPK3']",0.9999956133475378,0,0,5
356,Kallmann's Syndrome WP5074,0.6709246535269853,0.8899390243902439,0.35517327467494736,"['PROKR2', 'FGF8', 'GNRH1', 'SEMA3E', 'PRKCQ']",0.9999956133475378,0,0,5
357,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6709246535269853,0.8899390243902439,0.35517327467494736,"['GOT1', 'MDH2', 'SCO2', 'HMGA1', 'SLC2A1']",0.9999956133475378,0,0,5
358,Endometrial cancer WP4155,0.6731524919817499,0.9086771055506424,0.3596393048801971,"['GADD45B', 'BAD', 'GADD45A', 'TCF7', 'FGF1', 'ELK1', 'EGFR', 'GADD45G', 'CDH1', 'MYC', 'BAX', 'KRAS', 'CTNNA2', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,15
359,AGE/RAGE pathway WP2324,0.6743635895346977,0.9059354236572521,0.35692574986827946,"['JUN', 'PRKCD', 'FOXO4', 'FOXO1', 'EGFR', 'SOD1', 'NFKBIA', 'LGALS3', 'CASP8', 'ALPL', 'CYCS', 'RAC1', 'JAK2', 'MAPK3']",0.9999956133475378,0,0,14
360,15q13.3 copy number variation syndrome WP4942,0.6810070103315391,0.8762590737718755,0.33664355820826153,"['GOLGA8R', 'KAT2B', 'GOLGA8H', 'CHRFAM7A']",0.9999956133475378,0,0,4
361,Eukaryotic Transcription Initiation WP405,0.6828572065010016,0.8898046398046398,0.33943333936331754,"['TAF13', 'POLR2C', 'POLR2E', 'POLR1E', 'TAF7', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.9999956133475378,0,0,10
362,Integrated Cancer Pathway WP1971,0.6828572065010016,0.8898046398046398,0.33943333936331754,"['CDKN2B', 'CDKN1B', 'CASP8', 'BAD', 'MYC', 'CHEK2', 'E2F1', 'BCL2', 'BAX', 'CDC25A']",0.9999956133475378,0,0,10
363,Focal Adhesion WP306,0.6942266545538033,0.9279824373527522,0.3386734824357314,"['SHC4', 'SHC3', 'ITGB4', 'LAMC3', 'LAMA4', 'LAMA3', 'PDGFB', 'TNC', 'ELK1', 'THBS1', 'ACTB', 'EGFR', 'THBS4', 'MYL12B', 'ACTG1', 'PPP1CC', 'CCND3', 'CHAD', 'TNR', 'ITGB8', 'RAC1', 'HRAS', 'MAPK3', 'VAV3', 'JUN', 'CAV3', 'LAMB3', 'CAV2', 'BAD', 'HGF', 'FN1', 'VEGFC', 'PTK6', 'IGF1', 'VAV2', 'VEGFA', 'COL1A1', 'MYLPF', 'MYL5', 'HCK', 'ITGA10', 'ITGA11', 'BCL2', 'ITGA8', 'MYL9']",0.9999956133475378,0,0,45
364,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6964752490809379,0.8666263500753284,0.31347870275355044,"['YAP1', 'FYB1', 'RAB13', 'LPL', 'FOXO4', 'RAC1', 'FOXO1']",0.9999956133475378,0,0,7
365,Prion disease pathway WP3995,0.6964752490809379,0.8666263500753284,0.31347870275355044,"['PRNP', 'HSPA5', 'EBF1', 'BCL2', 'POU2F2', 'ELK1', 'MAPK3']",0.9999956133475378,0,0,7
366,Cysteine and methionine catabolism WP4504,0.6964799357349606,0.8543637250121892,0.3090372798689848,"['AHCY', 'GOT1', 'SQOR']",0.9999956133475378,0,0,3
367,Ganglio Sphingolipid Metabolism WP1423,0.6964799357349606,0.8543637250121892,0.3090372798689848,"['B3GALT1', 'B4GALNT1', 'FUT1']",0.9999956133475378,0,0,3
368,Hedgehog Signaling Pathway Netpath WP47,0.6964799357349606,0.8543637250121892,0.3090372798689848,"['PTCH1', 'SUFU', 'GLI2']",0.9999956133475378,0,0,3
369,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6990002408274663,0.8896699266503667,0.3185945304228524,"['EGR1', 'JUN', 'CDKN1B', 'KCNIP3', 'TSHR', 'MYL12B', 'CCND3', 'PAX8', 'MYC', 'APEX1', 'E2F1', 'JAK2', 'CGA', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,15
370,Aflatoxin B1 metabolism WP699,0.6999457385724291,0.9493989603638726,0.33870041773424986,['CYP3A4'],0.9999956133475378,0,0,1
371,MED and Pseudoachondroplasia genes WP4789,0.6999457385724291,0.9493989603638726,0.33870041773424986,['COL9A3'],0.9999956133475378,0,0,1
372,Sulindac Metabolic Pathway WP2542,0.6999457385724291,0.9493989603638726,0.33870041773424986,['CYP1B1'],0.9999956133475378,0,0,1
373,Vitamin B6-dependent and responsive disorders WP4228,0.6999457385724291,0.9493989603638726,0.33870041773424986,['PNPO'],0.9999956133475378,0,0,1
374,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7009828307545891,0.8857274776609902,0.3146740703649412,"['IFI27L2', 'JUN', 'VDR', 'PRKCD', 'ISG15', 'TNFRSF1A', 'RELB', 'PLCB4', 'CYP24A1', 'PRKCQ', 'KRAS', 'HRAS', 'TLR4', 'MAPK3']",0.9999956133475378,0,0,14
375,16p11.2 distal deletion syndrome WP4950,0.7037911511983418,0.8542571358868016,0.30007800257003236,"['C3', 'PLN', 'CD81', 'JAK2', 'TUFM', 'VAV2']",0.9999956133475378,0,0,6
376,Gastric Cancer Network 2 WP2363,0.7037911511983418,0.8542571358868016,0.30007800257003236,"['PLAC8', 'MYC', 'S100A6', 'CACYBP', 'COL9A3', 'EGFR']",0.9999956133475378,0,0,6
377,Signal transduction through IL1R WP4496,0.7037911511983418,0.8542571358868016,0.30007800257003236,"['NFKBIA', 'JUN', 'TGFB1', 'IRAK1', 'TOLLIP', 'MAP3K14']",0.9999956133475378,0,0,6
378,Hepatitis B infection WP4666,0.7080163466687998,0.9095774562349118,0.3140662689735628,"['YWHAB', 'ELK1', 'CASP8', 'IRAK1', 'MYC', 'CREB3L1', 'CREB3L2', 'FADD', 'IKBKG', 'JAK2', 'HRAS', 'MAPK3', 'JUN', 'EGR2', 'TICAM2', 'TGFB1', 'EGR3', 'ATP6AP1', 'SLC10A1', 'BAD', 'NFATC3', 'NFATC1', 'CREB3', 'IRF3', 'VDAC3', 'BCL2', 'CYCS', 'BAX', 'KRAS', 'TLR4', 'ATF4']",0.9999956133475378,0,0,31
379,Hippo-Merlin Signaling Dysregulation WP4541,0.7102165282929904,0.9007352941176471,0.30821845431385747,"['ITGB4', 'FOXM1', 'EGFR', 'CDH7', 'CDH6', 'PPP1CC', 'CDH3', 'CDH1', 'CDH20', 'MYC', 'ITGB8', 'HRAS', 'NTRK1', 'PPP1R14A', 'PLCB4', 'PRKAR1A', 'ITGA10', 'ITGA11', 'KIT', 'CDH11', 'ITGA8', 'KRAS', 'FGFR4', 'CD44', 'CDH19']",0.9999956133475378,0,0,25
380,1q21.1 copy number variation syndrome WP4905,0.7135176657246222,0.8375179340028694,0.28270257320305464,"['PYGO2', 'KIRREL1', 'ACP6', 'FMO5', 'TJP2']",0.9999956133475378,0,0,5
381,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7135176657246222,0.8375179340028694,0.28270257320305464,"['HPGD', 'ACOX2', 'TBXAS1', 'PTGDR', 'PTGES']",0.9999956133475378,0,0,5
382,Estrogen signaling pathway WP712,0.7135176657246222,0.8375179340028694,0.28270257320305464,"['JUN', 'GPER1', 'BCL2', 'IKBKG', 'ELK1']",0.9999956133475378,0,0,5
383,Fatty Acid Biosynthesis WP357,0.7135176657246222,0.8375179340028694,0.28270257320305464,"['ACLY', 'FASN', 'ACSL5', 'ECHDC3', 'ACACB']",0.9999956133475378,0,0,5
384,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7135176657246222,0.8375179340028694,0.28270257320305464,"['FSHR', 'CGA', 'SGK1', 'FOXO1', 'MAPK3']",0.9999956133475378,0,0,5
385,NRF2-ARE regulation WP4357,0.7135176657246222,0.8375179340028694,0.28270257320305464,"['AIMP2', 'CEBPB', 'MAF', 'KEAP1', 'HMOX1']",0.9999956133475378,0,0,5
386,PDGF Pathway WP2526,0.7181466468368561,0.854150390625,0.2827933816918284,"['NFKBIA', 'JUN', 'PDGFB', 'ARFIP2', 'RAC1', 'ELK1', 'HRAS', 'MAPK3', 'VAV2']",0.9999956133475378,0,0,9
387,Toll-like Receptor Signaling Pathway WP75,0.7192815837991872,0.8798656822629425,0.2899178235267506,"['CD86', 'JUN', 'TICAM2', 'CD80', 'LY96', 'PIK3R5', 'NFKBIA', 'CASP8', 'IRAK1', 'IRF3', 'TOLLIP', 'TLR9', 'FADD', 'RAC1', 'IKBKG', 'TLR4', 'MAPK3']",0.9999956133475378,0,0,17
388,"Degradation pathway of sphingolipids, including diseases WP4153",0.7228049350103243,0.8136903311166046,0.2641368131828092,"['NEU1', 'GLA']",0.9999956133475378,0,0,2
389,Estrogen Receptor Pathway WP2881,0.7228049350103243,0.8136903311166046,0.2641368131828092,"['JUN', 'CYP1B1']",0.9999956133475378,0,0,2
390,Leptin and adiponectin WP3934,0.7228049350103243,0.8136903311166046,0.2641368131828092,"['LEP', 'LEPR']",0.9999956133475378,0,0,2
391,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.7228049350103243,0.8136903311166046,0.2641368131828092,"['AHCY', 'MAT2B']",0.9999956133475378,0,0,2
392,Thiamine metabolic pathways WP4297,0.7228049350103243,0.8136903311166046,0.2641368131828092,"['BCKDK', 'TKT']",0.9999956133475378,0,0,2
393,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7235942987030156,0.8714385509705105,0.2819316383174659,"['CDKN1B', 'KIRREL2', 'NOTCH1', 'TGFB1', 'MME', 'ITGB4', 'CD80', 'DKK1', 'PAX2', 'MYO1E', 'COL4A3', 'COL4A5', 'VIM', 'UTRN', 'TLR4']",0.9999956133475378,0,0,15
394,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7239804781559982,0.8436163769334382,0.2724803713622854,"['IFITM3', 'JUN', 'IFITM2', 'IFI27', 'DDIT3', 'BCL2', 'JUNB', 'MAPK3']",0.9999956133475378,0,0,8
395,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7269323409925983,0.8135994705124185,0.25947466604308245,"['RAB27A', 'KRAS', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,4
396,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.7269323409925983,0.8135994705124185,0.25947466604308245,"['CD86', 'TGFB1', 'CD80', 'TLR4']",0.9999956133475378,0,0,4
397,Nicotine Activity on Dopaminergic Neurons WP1602,0.7269323409925983,0.8135994705124185,0.25947466604308245,"['CHRNB2', 'CHRNA5', 'DRD3', 'SLC18A2']",0.9999956133475378,0,0,4
398,The influence of laminopathies on Wnt signaling WP4844,0.7312001974360139,0.8304457458923052,0.25998597949544766,"['CEBPA', 'CEBPB', 'ICMT', 'CEBPD', 'TCF7', 'HES1', 'EMD']",0.9999956133475378,0,0,7
399,Cell Differentiation - Index expanded WP2023,0.7464726762419549,0.7766278090510172,0.2270830707872999,"['PAX7', 'ID2', 'MEF2D']",0.9999956133475378,0,0,3
400,Fatty acid transporters WP5061,0.7464726762419549,0.7766278090510172,0.2270830707872999,"['FABP7', 'ACSL5', 'ACSBG2']",0.9999956133475378,0,0,3
401,Leptin Insulin Overlap WP3935,0.7464726762419549,0.7766278090510172,0.2270830707872999,"['LEP', 'LEPR', 'JAK2']",0.9999956133475378,0,0,3
402,Riboflavin and CoQ disorders WP5037,0.7464726762419549,0.7766278090510172,0.2270830707872999,"['SLC52A2', 'RFK', 'PDSS2']",0.9999956133475378,0,0,3
403,Common Pathways Underlying Drug Addiction WP2636,0.7477125787040417,0.8265262726814516,0.24030146140772532,"['GRIA1', 'PPP1CC', 'GJB1', 'PPP1R1A', 'CALM1', 'CALM2', 'ACTB', 'ACTG1', 'MAPK3']",0.9999956133475378,0,0,9
404,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7520456205021956,0.7909214092140922,0.22537961333089454,"['POSTN', 'ANGPT2', 'SERPINE1', 'LTBP1', 'MAPK3']",0.9999956133475378,0,0,5
405,IL-2 signaling pathway WP49,0.754648308019935,0.813417483175843,0.22897983223889262,"['JUN', 'SYK', 'CISH', 'MYC', 'BCL2', 'NMI', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,8
406,Retinoblastoma gene in cancer WP2446,0.7576060211396621,0.8583354699360574,0.2382668790838539,"['CDT1', 'CDKN1B', 'RRM2', 'H2AFZ', 'SUV39H1', 'PRIM1', 'CDC25A', 'CCNA2', 'CCND3', 'CCNE2', 'TFDP2', 'MYC', 'RPA3', 'POLE2', 'STMN1', 'MCM3', 'E2F1', 'MCM4', 'POLE']",0.9999956133475378,0,0,19
407,PPAR signaling pathway WP3942,0.7580137467494115,0.8331416517194734,0.2308250255142994,"['CYP27A1', 'CPT2', 'ACOX2', 'FABP7', 'UCP1', 'APOA1', 'ACSL5', 'LPL', 'PLIN1', 'CPT1B', 'ACSBG2', 'PCK2']",0.9999956133475378,0,0,12
408,Ebola Virus Pathway on Host WP4217,0.7636137062727486,0.870403645645559,0.2347419773404135,"['VPS4A', 'ACTB', 'ASGR1', 'EGFR', 'ACTG1', 'RELB', 'SCIN', 'C1QBP', 'CLTCL1', 'RAC1', 'CTSB', 'MAPK3', 'VPS18', 'CAV3', 'CAV2', 'HLA-C', 'HLA-F', 'HLA-E', 'RHOB', 'VAV2', 'IRF3', 'AXL', 'NEDD4', 'HLA-DRA', 'MFGE8', 'TLR4']",0.9999956133475378,0,0,26
409,miRNA targets in ECM and membrane receptors WP2911,0.7677194027636097,0.7592944810208893,0.20070504940212264,"['LAMA4', 'ITGA11', 'FN1', 'THBS1']",0.9999956133475378,0,0,4
410,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7677194027636097,0.7592944810208893,0.20070504940212264,"['NFKBIA', 'IRF3', 'IKBKG', 'NFKBIE']",0.9999956133475378,0,0,4
411,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.7750629834959447,0.800628662109375,0.20400897713376343,"['MAP4K1', 'ACTA2', 'ACTA1', 'ACTC1', 'ITGB4', 'CDH1', 'ITGB8', 'ACTB', 'ACTG1']",0.9999956133475378,0,0,9
412,LTF danger signal response pathway WP4478,0.7775473032151803,0.7119181087009505,0.17912628246648943,"['IRAK1', 'TLR4']",0.9999956133475378,0,0,2
413,Mitochondrial fatty acid synthesis pathway WP4317,0.7779371280268584,0.7119883040935673,0.1787870771522805,['HSD17B12'],0.9999956133475378,0,0,1
414,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.7779371280268584,0.7119883040935673,0.1787870771522805,['FOXO1'],0.9999956133475378,0,0,1
415,The alternative pathway of fetal androgen synthesis WP4524,0.7779371280268584,0.7119883040935673,0.1787870771522805,['STAR'],0.9999956133475378,0,0,1
416,G13 Signaling Pathway WP524,0.7828224821453305,0.7853012717463578,0.19228048529367,"['CFL2', 'ARHGDIB', 'CFL1', 'ARHGDIG', 'RAC1', 'IQGAP2', 'CALM1', 'CALM2']",0.9999956133475378,0,0,8
417,miRNAs involvement in the immune response in sepsis WP4329,0.7865622139925502,0.7492297817715019,0.1798776762969817,"['NFKBIA', 'IRAK1', 'IKBKG', 'TLR4', 'RELB']",0.9999956133475378,0,0,5
418,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7865622139925502,0.7492297817715019,0.1798776762969817,"['PDGFB', 'IGF1', 'SOX6', 'GLI2', 'SOX5']",0.9999956133475378,0,0,5
419,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.7865622139925502,0.7492297817715019,0.1798776762969817,"['ACE2', 'IRF3', 'OAS1', 'TLR9', 'TLR4']",0.9999956133475378,0,0,5
420,RANKL/RANK signaling pathway WP2018,0.7868793065291164,0.8028196359901294,0.19242013248267323,"['LYN', 'NFKBIA', 'JUN', 'SYK', 'MITF', 'TNFRSF11B', 'NFATC1', 'RAC1', 'IKBKG', 'RELB', 'MAPK3']",0.9999956133475378,0,0,11
421,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.789638900564684,0.711847879083374,0.16812389460222774,"['FRAT1', 'GADD45G', 'WNT4']",0.9999956133475378,0,0,3
422,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.789638900564684,0.711847879083374,0.16812389460222774,"['FZD1', 'SFRP4', 'DKK3']",0.9999956133475378,0,0,3
423,Nuclear receptors WP170,0.7920924809734208,0.7664339077223411,0.1786382117748603,"['NR4A1', 'AR', 'VDR', 'RORA', 'NR1D2', 'ROR1', 'NR2F6']",0.9999956133475378,0,0,7
424,Pathways affected in adenoid cystic carcinoma WP3651,0.7935891096762274,0.813143834898907,0.18799027253932674,"['CEBPA', 'NOTCH1', 'MYCBP', 'UHRF1', 'CNTN6', 'INSRR', 'FOXP2', 'MORF4L1', 'MYC', 'CHEK2', 'MYB', 'HIST1H1E', 'FGFR4', 'HRAS']",0.9999956133475378,0,0,14
425,Sphingolipid pathway WP1422,0.8033322804879438,0.7426413653383116,0.16262869458391183,"['PPP2CA', 'CERS4', 'ACER1', 'GAL3ST1', 'SERINC1', 'SGMS2']",0.9999956133475378,0,0,6
426,Purine metabolism and related disorders WP4224,0.8035649513815042,0.7117776152158011,0.15566381524493308,"['PRPS1', 'RRM2B', 'AOX1', 'APRT']",0.9999956133475378,0,0,4
427,16p11.2 proximal deletion syndrome WP4949,0.8088062264879937,0.8053928126585782,0.17090106310764117,"['IGFBP3', 'MVP', 'GDPD3', 'TBX6', 'SEZ6L2', 'PPP2CA', 'CCT6A', 'CASP8', 'TCP1', 'TMEM219', 'ALDOA', 'CCT7', 'CDIPT', 'YPEL3', 'MAPK3']",0.9999956133475378,0,0,15
428,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8153178835156706,0.8129609563424097,0.16598809231513592,"['SHC4', 'SHC3', 'BAD', 'HGF', 'GAB1', 'PDGFB', 'NRG1', 'IGF1', 'EGFR', 'VEGFA', 'AXL', 'MYC', 'BCL2', 'BAX', 'KRAS', 'JAK2', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,18
429,Cannabinoid receptor signaling WP3869,0.8172155130377268,0.7117073170731707,0.14365985357754898,"['ADORA2A', 'PRKAR1A', 'CYP2C19', 'CYP3A4', 'MAPK3']",0.9999956133475378,0,0,5
430,Ethanol effects on histone modifications WP3996,0.8172155130377268,0.7117073170731707,0.14365985357754898,"['KAT2B', 'ALDH1A3', 'AHCY', 'ALDH1A2', 'ALDH1A1']",0.9999956133475378,0,0,5
431,Monoamine Transport WP727,0.8172155130377268,0.7117073170731707,0.14365985357754898,"['ADORA2A', 'TNFRSF11B', 'DBH', 'NOS1', 'AGT']",0.9999956133475378,0,0,5
432,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8183458747087655,0.7379842018690237,0.1479438420431644,"['MAP4K1', 'JUN', 'HGF', 'GAB1', 'ELK1', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,7
433,"NAD metabolism, sirtuins and aging WP3630",0.8225639169098782,0.6327619357109974,0.12359681235075437,"['ROS1', 'FOXO1']",0.9999956133475378,0,0,2
434,Osteopontin Signaling WP1434,0.8225639169098782,0.6327619357109974,0.12359681235075437,"['MAP3K14', 'MAPK3']",0.9999956133475378,0,0,2
435,Purine metabolism WP4792,0.8225639169098782,0.6327619357109974,0.12359681235075437,"['PRPS1', 'APRT']",0.9999956133475378,0,0,2
436,ATM Signaling Network in Development and Disease  WP3878,0.8231978823702487,0.7534036075367647,0.14658120152161275,"['DCLRE1C', 'KAT5', 'ATMIN', 'CHEK2', 'H2AFX', 'HSPB1', 'IKBKG', 'HMGN1', 'CDK5R1']",0.9999956133475378,0,0,9
437,TGF-beta Receptor Signaling WP560,0.8231978823702487,0.7534036075367647,0.14658120152161275,"['FKBP1A', 'JUN', 'TGFB1', 'SERPINE1', 'ZNF423', 'HRAS', 'LTBP1', 'THBS1', 'MAPK3']",0.9999956133475378,0,0,9
438,Glycosaminoglycan degradation WP4815,0.826500366650497,0.6570340921876758,0.12520107762762953,"['HPSE2', 'HYAL2', 'IDS']",0.9999956133475378,0,0,3
439,GABA receptor Signaling WP4159,0.8300464961309194,0.7116369846303977,0.13255915478653593,"['GABRA1', 'GABBR1', 'GAD2', 'GABRE', 'GABRD', 'AP2M1']",0.9999956133475378,0,0,6
440,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.834774379142794,0.6698509689171938,0.12097092873704268,"['H3F3B', 'SUV39H1', 'E2F1', 'HIST1H3E']",0.9999956133475378,0,0,4
441,Immune response to tuberculosis WP4197,0.834774379142794,0.6698509689171938,0.12097092873704268,"['OAS1', 'TAP1', 'JAK2', 'IFIT3']",0.9999956133475378,0,0,4
442,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.8356602058664822,0.569541910331384,0.10225168217112446,['CYP2C18'],0.9999956133475378,0,0,1
443,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.8356602058664822,0.569541910331384,0.10225168217112446,['GGT2'],0.9999956133475378,0,0,1
444,Metastatic brain tumor WP2249,0.8356602058664822,0.569541910331384,0.10225168217112446,['MYC'],0.9999956133475378,0,0,1
445,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.8356602058664822,0.569541910331384,0.10225168217112446,['SIX4'],0.9999956133475378,0,0,1
446,miRNA Biogenesis WP2338,0.8356602058664822,0.569541910331384,0.10225168217112446,['RAN'],0.9999956133475378,0,0,1
447,Molybdenum cofactor (Moco) biosynthesis WP4507,0.8356602058664822,0.569541910331384,0.10225168217112446,['AOX1'],0.9999956133475378,0,0,1
448,"Phase I biotransformations, non P450 WP136",0.8356602058664822,0.569541910331384,0.10225168217112446,['PON1'],0.9999956133475378,0,0,1
449,Wnt signaling pathway and pluripotency WP399,0.8399839128366479,0.8013515610184978,0.13973370609650987,"['FZD1', 'WNT10A', 'JUN', 'WNT5B', 'FZD5', 'PRKCD', 'TCF7', 'FZD9', 'WNT7A', 'PPM1J', 'NKD1', 'PPP2CA', 'WNT6', 'FRAT1', 'CCND3', 'MYC', 'PRKCQ', 'WNT2', 'CD44', 'WNT4']",0.9999956133475378,0,0,20
450,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8419371852602171,0.7115666178623719,0.12242494363802864,"['MAP1LC3A', 'EIF2B2', 'MSTN', 'IGFBP5', 'TNFSF9', 'IGF1', 'TNFRSF1A']",0.9999956133475378,0,0,7
451,Notch Signaling Pathway Netpath WP61,0.8420506027973301,0.7588240084697451,0.13045335705901728,"['PSENEN', 'APH1A', 'NOTCH3', 'NOTCH1', 'MAML2', 'HEY1', 'MYC', 'HEY2', 'HES1', 'JAK2', 'SKP1', 'DLL3']",0.9999956133475378,0,0,12
452,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.8434945537631675,0.7759724383196266,0.1320719319253714,"['JUN', 'TGFB1', 'GADD45B', 'BAD', 'GADD45A', 'TCF7', 'NTN1', 'GADD45G', 'MYC', 'BCL2', 'CYCS', 'BAX', 'KRAS', 'RAC1', 'MAPK3']",0.9999956133475378,0,0,15
453,Head and Neck Squamous Cell Carcinoma WP4674,0.8434945537631675,0.7759724383196266,0.1320719319253714,"['NOTCH1', 'CDKN2A', 'GAB1', 'KEAP1', 'EGFR', 'PIK3R5', 'VEGFA', 'FKBP1A', 'CASP8', 'TERT', 'SESN1', 'E2F1', 'KRAS', 'FADD', 'HRAS']",0.9999956133475378,0,0,15
454,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8440972335240348,0.7318150111607142,0.12403355921913362,"['ABCA1', 'CYP27A1', 'IDI1', 'HMGCS1', 'FASN', 'CYP51A1', 'MSMO1', 'DHCR24', 'HMGCR']",0.9999956133475378,0,0,9
455,Nucleotide Excision Repair WP4753,0.8440972335240348,0.7318150111607142,0.12403355921913362,"['POLE4', 'POLD4', 'CETN2', 'POLD1', 'RPA3', 'POLE2', 'POLD2', 'POLE3', 'POLE']",0.9999956133475378,0,0,9
456,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.8440972335240348,0.7318150111607142,0.12403355921913362,"['ACE2', 'CASP8', 'TGFB1', 'IRF3', 'CD160', 'CXCL17', 'FADD', 'CXCL13', 'CXCL5']",0.9999956133475378,0,0,9
457,Oxidative Stress WP408,0.8442212659072886,0.6777584204413473,0.11477205508498482,"['GPX3', 'HMOX1', 'SOD2', 'JUNB', 'SOD1']",0.9999956133475378,0,0,5
458,ESC Pluripotency Pathways WP3931,0.8479391565479204,0.8022884128688684,0.1323345815478295,"['FZD1', 'WNT10A', 'JUN', 'WNT5B', 'FZD5', 'PDGFB', 'FZD9', 'GAB1', 'WNT7A', 'FGF1', 'ELK1', 'EGFR', 'FGF17', 'WNT6', 'FGF7', 'FGF8', 'IL6ST', 'FGFR4', 'WNT2', 'HRAS', 'WNT4', 'FGF10']",0.9999956133475378,0,0,22
459,Amino Acid metabolism WP3925,0.8504618491883731,0.7800564989583991,0.12635021701723426,"['AOC3', 'TPH1', 'OAT', 'GOT1', 'ARG1', 'MDH2', 'ODC1', 'PYCR1', 'DBH', 'ASS1', 'ACLY', 'TPO', 'LDHA', 'PKM', 'ALDH1A1', 'HIBCH', 'OTC']",0.9999956133475378,0,0,17
460,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.857677450280443,0.6100508462770774,0.09365938745718815,"['CYP24A1', 'ALPL', 'ROS1']",0.9999956133475378,0,0,3
461,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.857677450280443,0.6100508462770774,0.09365938745718815,"['JUN', 'PRKCQ', 'MAPK3']",0.9999956133475378,0,0,3
462,PPAR-alpha pathway WP2878,0.857677450280443,0.6100508462770774,0.09365938745718815,"['CPT2', 'MYC', 'APOA1']",0.9999956133475378,0,0,3
463,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.8592116867916431,0.5694369973190349,0.08640634342288375,"['GABBR1', 'GRM4']",0.9999956133475378,0,0,2
464,Serotonin and anxiety-related events WP3944,0.8592116867916431,0.5694369973190349,0.08640634342288375,"['ARC', 'CRH']",0.9999956133475378,0,0,2
465,Integrated breast cancer pathway WP1984,0.8615604827011974,0.8197070136672395,0.1221445578522833,"['GSK3A', 'ODC1', 'MAP3K7CL', 'PHB', 'HMGCR', 'JAKMIP1', 'TFPI', 'FOXO1', 'EGFR', 'RASGRP3', 'CASP8', 'CDH1', 'MYC', 'CHEK2', 'E2F1', 'RHO', 'FADD', 'RAC1', 'RPP38', 'PLK3', 'JUN', 'GADD45A', 'BAD', 'CDC25A', 'FOSL2', 'VEGFA', 'AR', 'RAD51', 'BCL2', 'BAX', 'KRAS', 'FAU']",0.9999956133475378,0,0,32
466,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8633257970063137,0.8161602938235241,0.1199454814261629,"['SHC4', 'GRIA1', 'RAB3A', 'SHC3', 'NCF2', 'ELK1', 'ACACB', 'PPP2CA', 'GRIP1', 'RPS6KA5', 'CFL1', 'RACK1', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'MAPK3', 'NSF', 'VAV3', 'NTRK1', 'EGR1', 'JUN', 'EGR2', 'BAD', 'PRKCD', 'EEF2', 'NGF', 'VAV2', 'NFKBIA', 'ALPL', 'CDK5R1']",0.9999956133475378,0,0,31
467,MAPK Signaling Pathway WP382,0.8651211508980997,0.8509364141862008,0.12328853760988065,"['HSPB1', 'FGF1', 'ELK1', 'FGF7', 'RPS6KA5', 'FGF8', 'MYC', 'STMN1', 'RAC1', 'IKBKG', 'HRAS', 'MAP4K1', 'DUSP4', 'DUSP2', 'DUSP3', 'PLA2G4D', 'DUSP1', 'PLA2G4E', 'PRKCD', 'NGF', 'DUSP6', 'DUSP7', 'TNFRSF1A', 'DDIT3', 'ATF4', 'PDGFB', 'CACNA1A', 'EGFR', 'RASGRP4', 'RELB', 'RASGRP3', 'PPP3R2', 'CACNG2', 'CACNG4', 'CACNG5', 'MAPK3', 'NTRK1', 'HSPA8', 'JUN', 'TGFB1', 'GADD45A', 'NFATC3', 'NFATC1', 'GNG12', 'FGF17', 'NR4A1', 'KRAS', 'PTPN7', 'FGFR4', 'LAMTOR3', 'MAP3K14', 'HSPA1B', 'FGF10']",0.9999956133475378,0,0,53
468,DNA IR-double strand breaks and cellular response via ATM WP3959,0.865358545544083,0.727888799263812,0.1052609851242754,"['YAP1', 'DCLRE1C', 'RAD51', 'KAT5', 'CDKN2A', 'CHEK2', 'H2AFX', 'E2F1', 'BAX', 'MCPH1', 'RAD9A']",0.9999956133475378,0,0,11
469,Intraflagellar transport proteins binding to dynein WP4532,0.8678399453979774,0.6468957871396895,0.09169616852768421,"['IFT140', 'DYNLT3', 'WDR19', 'DYNLL1', 'DYNLL2']",0.9999956133475378,0,0,5
470,Lipid Metabolism Pathway WP3965,0.8678399453979774,0.6468957871396895,0.09169616852768421,"['ACLY', 'PRKAR1A', 'FASN', 'HILPDA', 'PLIN1']",0.9999956133475378,0,0,5
471,Nanoparticle-mediated activation of receptor signaling WP2643,0.8678399453979774,0.6468957871396895,0.09169616852768421,"['COL1A1', 'FN1', 'KRAS', 'HRAS', 'EGFR']",0.9999956133475378,0,0,5
472,Leptin signaling pathway WP2034,0.8731756016953015,0.7486166516535838,0.10152633920404491,"['GSK3A', 'CISH', 'BAD', 'ELK1', 'ACACB', 'FOXO1', 'CFL2', 'LEP', 'LEPR', 'BAX', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,15
473,Prolactin Signaling Pathway WP2037,0.8731756016953015,0.7486166516535838,0.10152633920404491,"['JUN', 'CISH', 'ELK1', 'PRLR', 'VAV2', 'NFKBIA', 'ZAP70', 'MYC', 'PTPN6', 'RAC1', 'JAK2', 'CTSD', 'HRAS', 'YWHAG', 'MAPK3']",0.9999956133475378,0,0,15
474,Pancreatic adenocarcinoma pathway WP4263,0.8738766630174948,0.7641630360553484,0.10302142764471052,"['TGFB1', 'GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'PRKCD', 'PEBP1', 'DUSP6', 'EGFR', 'VEGFA', 'GADD45G', 'RAD51', 'E2F1', 'BAX', 'KRAS', 'RAC1', 'IKBKG', 'MAPK3']",0.9999956133475378,0,0,18
475,Pathways Regulating Hippo Signaling WP4540,0.8738766630174948,0.7641630360553484,0.10302142764471052,"['NTRK1', 'PRKCD', 'TCF7', 'EGFR', 'CDH7', 'CDH6', 'CDH3', 'PLCB4', 'CDH1', 'PRKD3', 'PRKAR1A', 'CDH20', 'KIT', 'CDH11', 'PRKCQ', 'RAC1', 'FGFR4', 'CDH19']",0.9999956133475378,0,0,18
476,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8747008898742251,0.6567830803010115,0.08792571257023268,"['HEXIM1', 'NFKBIA', 'PPP3R2', 'SUPT4H1', 'NFATC3', 'NFATC1']",0.9999956133475378,0,0,6
477,Neural Crest Cell Migration during Development WP4564,0.8747008898742251,0.6567830803010115,0.08792571257023268,"['ARF1', 'JUN', 'CDH11', 'RAC1', 'PIK3R5', 'EPHB3']",0.9999956133475378,0,0,6
478,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8777184375426971,0.7555497798434442,0.0985459217933743,"['KLB', 'NOTCH1', 'BAD', 'DIO1', 'UCP1', 'FOXO1', 'TSHR', 'MC4R', 'CREB3', 'TPO', 'PAX8', 'NPY', 'NPPA', 'PRKCQ', 'PLIN1', 'HRAS', 'WNT4']",0.9999956133475378,0,0,17
479,Caloric restriction and aging WP4191,0.8783813191714009,0.47457764782326184,0.061540607486909614,['IGF1'],0.9999956133475378,0,0,1
480,"Cerebral organic acidurias, including diseases WP4519",0.8783813191714009,0.47457764782326184,0.061540607486909614,['MDH2'],0.9999956133475378,0,0,1
481,Glucuronidation WP698,0.8783813191714009,0.47457764782326184,0.061540607486909614,['PGM5'],0.9999956133475378,0,0,1
482,LDLRAD4 and what we know about it WP4904,0.8783813191714009,0.47457764782326184,0.061540607486909614,['NEDD4'],0.9999956133475378,0,0,1
483,Pentose Phosphate Metabolism WP134,0.8783813191714009,0.47457764782326184,0.061540607486909614,['TKT'],0.9999956133475378,0,0,1
484,Hedgehog Signaling Pathway WP4249,0.8817165279345163,0.6640149666503986,0.08358930597047178,"['EVC', 'HHIP', 'SUFU', 'PTCH1', 'BOC', 'BCL2', 'GLI2']",0.9999956133475378,0,0,7
485,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.8838264078327495,0.5693320331545587,0.07030943560595683,"['MDH2', 'IDH3B', 'IDH3A']",0.9999956133475378,0,0,3
486,PDGFR-beta pathway WP3972,0.888357731441021,0.6187168610816542,0.07324417619367121,"['JUN', 'JAK2', 'ELK1', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,5
487,Chemokine signaling pathway WP3929,0.8914681602777736,0.7832921299956962,0.08998895272039889,"['SHC4', 'ITK', 'SHC3', 'CXCL13', 'CXCL5', 'PIK3R5', 'GNG10', 'GNG3', 'GRK5', 'GNG8', 'RAC1', 'IKBKG', 'JAK2', 'HRAS', 'MAPK3', 'LYN', 'VAV3', 'PRKCD', 'GNG12', 'GNG11', 'VAV2', 'NFKBIA', 'HCK', 'PLCB4', 'GNB4', 'KRAS', 'DOCK2']",0.9999956133475378,0,0,27
488,MAPK Cascade WP422,0.893058270991587,0.6324035672657288,0.07152702345684323,"['JUN', 'KRAS', 'ELK1', 'HRAS', 'LAMTOR3', 'MAPK3']",0.9999956133475378,0,0,6
489,Target Of Rapamycin (TOR) Signaling WP1471,0.893058270991587,0.6324035672657288,0.07152702345684323,"['FKBP1A', 'IDI1', 'RRAGA', 'RRAGC', 'HMGCR', 'RAC1']",0.9999956133475378,0,0,6
490,Kit receptor signaling pathway WP304,0.8949058435103178,0.6954187700157412,0.0772170533406707,"['LYN', 'BAD', 'INPP5D', 'KIT', 'BCL2', 'MITF', 'PTPN6', 'JAK2', 'JUNB', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,11
491,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8952475468816766,0.6738666735197368,0.07456672366968654,"['FKBP1A', 'JUN', 'TGFB1', 'SERPINE1', 'ZNF423', 'HRAS', 'LTBP1', 'THBS1', 'MAPK3']",0.9999956133475378,0,0,9
492,AMP-activated protein kinase (AMPK) signaling WP1403,0.9016063151881912,0.6966398579954826,0.07215608382406133,"['GYS2', 'CCNA2', 'GYS1', 'FASN', 'LEP', 'LEPR', 'HMGCR', 'ADRA1B', 'EEF2', 'ADRA1A', 'CPT1B', 'ACACB']",0.9999956133475378,0,0,12
493,Ras signaling WP4223,0.9019589978379731,0.7957641277641277,0.08211188988480275,"['SHC4', 'SHC3', 'CALML6', 'FOXO4', 'ELK1', 'ETS2', 'RASGRP4', 'EGFR', 'RASGRP3', 'GNG10', 'GNG3', 'HTR7', 'GNG8', 'RAC1', 'IKBKG', 'HRAS', 'MAPK3', 'NTRK1', 'PLA2G4D', 'PLA2G4E', 'BAD', 'GAB1', 'KSR2', 'GNG12', 'GNG11', 'ZAP70', 'PLA2G10', 'KIT', 'GNB4', 'CALM3', 'KRAS', 'CALM1', 'FGFR4', 'CALM2', 'ARF6']",0.9999956133475378,0,0,35
494,Non-small cell lung cancer WP4255,0.9028718337397454,0.7110730872647274,0.07265365766863471,"['GADD45B', 'CDKN2A', 'BAD', 'GADD45A', 'FHIT', 'EGFR', 'GADD45G', 'CASP8', 'E2F1', 'CYCS', 'BAX', 'KRAS', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,14
495,Interleukin-11 Signaling Pathway WP2332,0.9035612235462774,0.6503434568848286,0.06595224603940368,"['TGFB1', 'BGLAP', 'FES', 'BCL2', 'JAK2', 'IL6ST', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,8
496,Aspirin and miRNAs WP4707,0.9099986999602473,0.40674603174603174,0.038361075710142474,['VEGFA'],0.9999956133475378,0,0,1
497,Disorders of Folate Metabolism and Transport WP4259,0.9099986999602473,0.40674603174603174,0.038361075710142474,['ALDH1L1'],0.9999956133475378,0,0,1
498,Methylation Pathways WP704,0.9099986999602473,0.40674603174603174,0.038361075710142474,['MAT2B'],0.9999956133475378,0,0,1
499,Mitochondrial CII Assembly WP4920,0.9099986999602473,0.40674603174603174,0.038361075710142474,['SDHAF1'],0.9999956133475378,0,0,1
500,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.9099986999602473,0.40674603174603174,0.038361075710142474,['TGFB1'],0.9999956133475378,0,0,1
501,Mammalian disorder of sexual development WP4842,0.9125202071123857,0.4744495897310911,0.04343351093521143,"['AMH', 'WNT4']",0.9999956133475378,0,0,2
502,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.9125202071123857,0.4744495897310911,0.04343351093521143,"['IRF3', 'OAS1']",0.9999956133475378,0,0,2
503,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9167754077327146,0.6322241206302714,0.05493569714122499,"['ADCY10', 'TGFB1', 'CFL1', 'BANF1', 'KRAS', 'HRAS', 'EMD', 'MAPK3']",0.9999956133475378,0,0,8
504,One-carbon metabolism and related pathways WP3940,0.9167754077327146,0.6322241206302714,0.05493569714122499,"['DMGDH', 'GPX2', 'GPX4', 'GPX3', 'CHDH', 'GAD2', 'SOD2', 'SOD1']",0.9999956133475378,0,0,8
505,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9190792079637172,0.6992865445508838,0.05900787624014199,"['FZD1', 'TGFB1', 'CISH', 'NRG1', 'IGF1', 'AGT', 'NPPA', 'RAC1', 'IKBKG', 'IL6ST', 'CALM1', 'CALM2', 'MAP3K14', 'PRKG1', 'MAPK3']",0.9999956133475378,0,0,15
506,Tumor suppressor activity of SMARCB1 WP4204,0.9212762363401429,0.5691219512195121,0.04666535746289909,"['H3F3B', 'CDKN2A', 'PTCH1', 'DPF3', 'GLI2']",0.9999956133475378,0,0,5
507,Neural Crest Cell Migration in Cancer WP4565,0.9229571245223653,0.588688578374877,0.047196633791942076,"['ARF1', 'JUN', 'CDH11', 'RAC1', 'PIK3R5', 'EPHB3']",0.9999956133475378,0,0,6
508,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9314249468773586,0.4379159714280358,0.03110940369542213,"['ACLY', 'IDH3A']",0.9999956133475378,0,0,2
509,TGF-beta Signaling Pathway WP366,0.9330906831441937,0.7388869821034567,0.051170057145634155,"['YAP1', 'CITED1', 'ITGB4', 'TNC', 'NEDD9', 'THBS1', 'PARD6A', 'TERT', 'SUMO1', 'MYC', 'RAC1', 'JUNB', 'SKP1', 'MAP4K1', 'KLF10', 'JUN', 'CDKN2B', 'TGFB1', 'LIMK2', 'FN1', 'KLF6', 'RBL1', 'ZEB1', 'STRAP', 'FOSB', 'ATF3']",0.9999956133475378,0,0,26
510,15q11.2 copy number variation syndrome WP4940,0.9333978154922118,0.3558723196881092,0.02452806755072011,['TUBGCP4'],0.9999956133475378,0,0,1
511,ATR Signaling WP3875,0.9333978154922118,0.3558723196881092,0.02452806755072011,['RAD9A'],0.9999956133475378,0,0,1
512,Biotin Metabolism (including IEMs) WP5031,0.9333978154922118,0.3558723196881092,0.02452806755072011,['ACACB'],0.9999956133475378,0,0,1
513,Cell Differentiation - Index WP2029,0.9333978154922118,0.3558723196881092,0.02452806755072011,['MEF2D'],0.9999956133475378,0,0,1
514,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.9333978154922118,0.3558723196881092,0.02452806755072011,['HMOX1'],0.9999956133475378,0,0,1
515,NLR Proteins WP288,0.9333978154922118,0.3558723196881092,0.02452806755072011,['IKBKG'],0.9999956133475378,0,0,1
516,Serotonin Transporter Activity WP1455,0.9333978154922118,0.3558723196881092,0.02452806755072011,['NOS1'],0.9999956133475378,0,0,1
517,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9342582416574354,0.5471857410881801,0.03720993760560497,"['NFKBIA', 'JUN', 'IRF3', 'OAS1', 'IKBKG']",0.9999956133475378,0,0,5
518,Histone Modifications WP2369,0.9385905164180045,0.5988463959508241,0.03795247699627325,"['SET', 'SETBP1', 'H3F3B', 'SETD9', 'SUV39H1', 'EHMT1', 'SMYD1', 'HIST1H3E']",0.9999956133475378,0,0,8
519,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.9409641117158524,0.6094796316964286,0.037087005375682304,"['DDX3Y', 'NFKBIA', 'CASP8', 'TKFC', 'IRF3', 'IFNE', 'ISG15', 'IKBKG', 'FADD']",0.9999956133475378,0,0,9
520,EGF/EGFR signaling pathway WP437,0.9449244236988262,0.7450906207612707,0.04220962925428009,"['NDUFA13', 'PEBP1', 'NEDD8', 'FOXO4', 'ELK1', 'FOXO1', 'EGFR', 'RPS6KA5', 'INPP5D', 'CFL1', 'STMN1', 'E2F1', 'RAC1', 'JAK2', 'HRAS', 'MEF2D', 'AP2M1', 'MAP4K1', 'VAV3', 'JUN', 'CAV2', 'LIMK2', 'PRKCD', 'GAB1', 'PTK6', 'EPN1', 'VAV2', 'NEDD4', 'SPRY2', 'FOSB', 'KRAS', 'ARF6']",0.9999956133475378,0,0,32
521,Fatty acid beta-oxidation WP143,0.9452873349554852,0.5268744354110207,0.029645295883448358,"['TPI1', 'CPT2', 'LPL', 'ACSL5', 'CPT1B']",0.9999956133475378,0,0,5
522,Notch Signaling WP268,0.9460911030470774,0.5689116642264519,0.03152704268410403,"['APH1A', 'NOTCH3', 'KCNJ5', 'KAT2B', 'NOTCH1', 'HES1', 'DLL3']",0.9999956133475378,0,0,7
523,Overview of interferons-mediated signaling pathway WP4558,0.9464140980802228,0.40660144145398835,0.022393602807259223,"['IFNE', 'JAK2']",0.9999956133475378,0,0,2
524,SARS coronavirus and innate immunity WP4912,0.9464140980802228,0.40660144145398835,0.022393602807259223,"['ACE2', 'IRF3']",0.9999956133475378,0,0,2
525,Resistin as a regulator of inflammation WP4481,0.9467391979104866,0.49485279306213753,0.02708409597538326,"['NFKBIA', 'PLCB4', 'IKBKG', 'MAPK3']",0.9999956133475378,0,0,4
526,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9474813473552696,0.5834412922526176,0.031475507397124125,"['NFKBIA', 'RPS6KA5', 'IRAK1', 'MYC', 'TOLLIP', 'ELK1', 'MAP3K14', 'MAPK3']",0.9999956133475378,0,0,8
527,NAD+ biosynthetic pathways WP3645,0.9505147008302169,0.44931868921450385,0.02280366519286788,"['NMNAT1', 'ACMSD', 'IDO1']",0.9999956133475378,0,0,3
528,Non-homologous end joining WP438,0.9507144382471344,0.3163038769763916,0.015986484028059963,['DCLRE1C'],0.9999956133475378,0,0,1
529,TCA cycle in senescence WP5050,0.9507144382471344,0.3163038769763916,0.015986484028059963,['GOT1'],0.9999956133475378,0,0,1
530,Valproic acid pathway WP3871,0.9507144382471344,0.3163038769763916,0.015986484028059963,['CYP2A6'],0.9999956133475378,0,0,1
531,Regulation of Actin Cytoskeleton WP51,0.9515037716699399,0.7231163734474992,0.03594729239885403,"['CHRM2', 'CHRM1', 'CHRM5', 'PDGFB', 'BRK1', 'FGF1', 'ACTB', 'EGFR', 'ACTG1', 'PIK3R5', 'FGF7', 'FGF8', 'CFL2', 'TMSB4X', 'CFL1', 'PIP4K2C', 'RAC1', 'WASF2', 'MAPK3', 'F2R', 'RASSF7', 'FN1', 'GNG12', 'FGF17', 'VIL1', 'KRAS', 'FGFR4', 'FGF10']",0.9999956133475378,0,0,28
532,Regulation of Microtubule Cytoskeleton WP2038,0.9543607648392635,0.5530611138224608,0.025835430743364907,"['SPRED1', 'PARD6A', 'CFL2', 'STMN1', 'RHO', 'RAC1', 'PHLDB2']",0.9999956133475378,0,0,7
533,Glioblastoma signaling pathways WP2261,0.9561123411971904,0.6460324516559235,0.028993846710722505,"['CDKN2B', 'CDKN1B', 'CDKN2C', 'CDKN2A', 'PRKCD', 'GAB1', 'FOXO4', 'FOXO1', 'EGFR', 'E2F1', 'SPRY2', 'PRKCQ', 'KRAS', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,15
534,Canonical and non-canonical TGF-B signaling WP3874,0.9582455791435476,0.3794621821431473,0.016184512945707163,"['TGFB1', 'LOXL1']",0.9999956133475378,0,0,2
535,"GPCRs, Class B Secretin-like WP334",0.9582455791435476,0.3794621821431473,0.016184512945707163,"['ADGRE2', 'ADGRG2']",0.9999956133475378,0,0,2
536,EPO Receptor Signaling WP581,0.9603704068980113,0.42681618722574355,0.017258836839503498,"['CISH', 'JAK2', 'MAPK3']",0.9999956133475378,0,0,3
537,Sphingolipid Metabolism (general overview) WP4725,0.9603704068980113,0.42681618722574355,0.017258836839503498,"['CERS4', 'SMPD1', 'SGMS2']",0.9999956133475378,0,0,3
538,G Protein Signaling Pathways WP35,0.9633604605660766,0.6404541211563831,0.023906632662389078,"['GNAZ', 'PRKCD', 'AKAP5', 'GNG12', 'GNG11', 'GNG10', 'GNG3', 'GNA15', 'PRKD3', 'PRKAR1A', 'GNG8', 'PRKCQ', 'KRAS', 'CALM1', 'HRAS', 'CALM2']",0.9999956133475378,0,0,16
539,DNA IR-damage and cellular response via ATR WP4016,0.9644649450969205,0.6217611830848203,0.022496434081691972,"['FEN1', 'ABRAXAS1', 'H2AFX', 'FOXM1', 'SEM1', 'BRIP1', 'RAD51', 'CHEK2', 'E2F1', 'USP1', 'IKBKG', 'MCM2', 'MCPH1', 'RAD9A']",0.9999956133475378,0,0,14
540,MTHFR deficiency WP4288,0.9683576901564813,0.4064567806644842,0.013069107815093116,"['CHDH', 'EHMT1', 'CYCS']",0.9999956133475378,0,0,3
541,Sphingolipid Metabolism (integrated pathway) WP4726,0.9683576901564813,0.4064567806644842,0.013069107815093116,"['CERS4', 'SMPD1', 'SGMS2']",0.9999956133475378,0,0,3
542,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9683576901564813,0.4064567806644842,0.013069107815093116,"['JUP', 'MYC', 'DKK1']",0.9999956133475378,0,0,3
543,MECP2 and Associated Rett Syndrome WP3584,0.9697660543452741,0.5790678318768206,0.017777624292604727,"['GRIA1', 'MPP1', 'REST', 'CEBPD', 'SST', 'E2F1', 'TAP1', 'IGF1', 'SGK1', 'POU3F2', 'FKBP5']",0.9999956133475378,0,0,11
544,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9697660543452741,0.5790678318768206,0.017777624292604727,"['DUSP2', 'CSF3R', 'STMN1', 'F2R', 'JAK2', 'IL6ST', 'CSF2RA', 'MAPK15', 'EGFR', 'MAPK3', 'IL12RB2']",0.9999956133475378,0,0,11
545,NO metabolism in cystic fibrosis WP4947,0.9730127311510703,0.2587497784866206,0.007078905536516893,['NOS1'],0.9999956133475378,0,0,1
546,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9745521305318113,0.4587332808811959,0.011824890180508526,"['GABRA1', 'SLC12A5', 'JAK2', 'GABRE', 'GABRD']",0.9999956133475378,0,0,5
547,MET in type 1 papillary renal cell carcinoma WP4205,0.9769588509044501,0.53302001953125,0.012425094091737032,"['JUN', 'BAD', 'HGF', 'RPL11', 'GAB1', 'KRAS', 'RAC1', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,9
548,ErbB signaling pathway WP673,0.9773761466157058,0.6002789352250422,0.013736602697675576,"['SHC4', 'JUN', 'CDKN1B', 'SHC3', 'BAD', 'GAB1', 'NRG1', 'ELK1', 'FOXO1', 'EGFR', 'ERBB4', 'MYC', 'KRAS', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,15
549,Mesodermal commitment pathway WP2857,0.9791088291630007,0.644083716491058,0.013598203958800537,"['VAV3', 'YAP1', 'TBX1', 'FZD5', 'SLC2A12', 'TBX6', 'DKK1', 'GRHL2', 'PPP2CA', 'ARL4A', 'FGF8', 'CSRP2', 'KLF5', 'PRKAR1A', 'SESN1', 'C1QBP', 'BHLHE40', 'RPL38', 'TOX', 'AMH', 'JAK2', 'NODAL']",0.9999956133475378,0,0,22
550,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9799903570631819,0.3710491170796854,0.007499847754413267,"['PPP2CA', 'RBL1', 'MAPK3']",0.9999956133475378,0,0,3
551,SARS-CoV-2 mitochondrial interactions WP5038,0.9799903570631819,0.3710491170796854,0.007499847754413267,"['ACE2', 'IRF3', 'PHB']",0.9999956133475378,0,0,3
552,GPR40 Pathway WP3958,0.9800304394821037,0.23716699155295645,0.0047840488582924535,['ITPR3'],0.9999956133475378,0,0,1
553,IL-9 signaling pathway WP22,0.9800304394821037,0.23716699155295645,0.0047840488582924535,['MAPK3'],0.9999956133475378,0,0,1
554,Triacylglyceride synthesis WP325,0.9805288938063086,0.3161372437511848,0.006216258893700285,"['LPL', 'AGPAT1']",0.9999956133475378,0,0,2
555,IL-1 signaling pathway WP195,0.9805620651792677,0.5053887668483714,0.009920445828751874,"['NFKBIA', 'JUN', 'IRAK1', 'TOLLIP', 'PELI2', 'IKBKG', 'MAP3K14', 'MAPK3']",0.9999956133475378,0,0,8
556,BDNF-TrkB Signaling WP3676,0.981140493226854,0.4063120493259484,0.007736025140352531,"['ARC', 'GAB1', 'KRAS', 'HRAS']",0.9999956133475378,0,0,4
557,Ciliary landscape WP4352,0.9828900123839197,0.70908195914349,0.012237375334672314,"['YAP1', 'SSNA1', 'VPS4A', 'USH1C', 'HTRA2', 'COPS7A', 'MYL6B', 'IQGAP2', 'IQGAP3', 'PSMD8', 'PSMD7', 'EXOSC4', 'APMAP', 'ARHGDIA', 'NEFL', 'BBS9', 'NEFM', 'TMED1', 'RAC1', 'DCAF11', 'NINL', 'CEP290', 'EXOC8', 'NDUFA5', 'IFT140', 'DYNLT3', 'DYNLL1', 'COX6C', 'DYNLL2', 'LSM4', 'GID8', 'ERF', 'MCM3', 'CD2BP2', 'MCM4', 'VIM', 'CALM1', 'COPS8', 'CALM2', 'GLA', 'ARL8B', 'MCM2']",0.9999956133475378,0,0,42
558,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9834827809289287,0.5262967485189708,0.008765550900885249,"['ACLY', 'IDI1', 'GSK3A', 'RBP4', 'HMGCS1', 'INSIG1', 'FASN', 'CYP51A1', 'LPL', 'HMGCR']",0.9999956133475378,0,0,10
559,Endoderm differentiation WP2853,0.9848121901193586,0.6211128795298727,0.009505713941096545,"['VAV3', 'DUSP4', 'DUSP5', 'DUSP2', 'NOTCH1', 'TGFB1', 'TCF7', 'ONECUT1', 'SLC2A12', 'WNT8A', 'DKK1', 'GRHL2', 'FOXO1', 'GLI2', 'NME1', 'MAD2L2', 'SESN1', 'C1QBP', 'TCEAL2', 'TOX', 'NODAL']",0.9999956133475378,0,0,21
560,Omega-9 FA synthesis WP4724,0.9852234529891795,0.2189046333783176,0.003258791184229237,['FASN'],0.9999956133475378,0,0,1
561,Autophagy WP4923,0.9874679293643255,0.3413066796684544,0.004304307047446851,"['MAP1LC3B', 'ATG101', 'ATG9A']",0.9999956133475378,0,0,3
562,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9875467882830338,0.4373674629834669,0.005480827845668169,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'PIM1', 'PIM2', 'MAPK3']",0.9999956133475378,0,0,6
563,DNA Repair Pathways Full Network WP4946,0.9882290948606379,0.608332167342941,0.007203097384477942,"['FEN1', 'DCLRE1C', 'CENPX', 'MGMT', 'CETN2', 'H2AFX', 'FANCE', 'FANCF', 'POLE4', 'POLD4', 'BRIP1', 'NEIL2', 'RAD51', 'POLD1', 'RPA3', 'POLE2', 'APEX1', 'POLD2', 'POLE3', 'USP1', 'POLE']",0.9999956133475378,0,0,21
564,Nanoparticle triggered autophagic cell death WP2509,0.9884075268505682,0.28447477455520354,0.003317029839006969,"['MAP1LC3A', 'BCL2']",0.9999956133475378,0,0,2
565,Trans-sulfuration and one-carbon metabolism WP2525,0.9910776731033312,0.27090514489978296,0.002427951930472872,"['AHCY', 'MAT2B']",0.9999956133475378,0,0,2
566,Joubert Syndrome WP4656,0.9914225594732958,0.504002710496872,0.004341700346765883,"['TMEM17', 'KAT5', 'CETN2', 'SUFU', 'BBS9', 'ARL2', 'PDE6B', 'PDE6A', 'ZNF423', 'CEP290', 'ATF4']",0.9999956133475378,0,0,11
567,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9919095231376166,0.1896848602988954,0.0015408826502603772,['MAPK3'],0.9999956133475378,0,0,1
568,Phosphoinositides metabolism WP4971,0.9921481659896928,0.3554011216776396,0.002801563771467622,"['PIP4P1', 'PLCB4', 'INPP5D', 'PIP4K2C']",0.9999956133475378,0,0,4
569,Ectoderm Differentiation WP2858,0.9923589818378263,0.5946001422856676,0.004560797329480227,"['EDA', 'FZD5', 'JUP', 'ARHGDIG', 'TNFRSF11B', 'NFATC1', 'POU2F2', 'JAKMIP1', 'CELSR2', 'VAX2', 'CDH6', 'PLCXD3', 'PPFIBP2', 'MYC', 'BOC', 'PIM1', 'HESX1', 'SPRY2', 'DMD', 'CTNNA2', 'ZBTB7B', 'LY6E']",0.9999956133475378,0,0,22
570,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9925301795514337,0.38414634146341464,0.0028802752091436064,"['MAP1LC3A', 'ATG101', 'GTPBP2', 'CP', 'FTL']",0.9999956133475378,0,0,5
571,Integrin-mediated Cell Adhesion WP185,0.9928646448544335,0.539119804400978,0.003860601088693245,"['VAV3', 'SHC3', 'CAV3', 'CAV2', 'ITGB4', 'VAV2', 'CAPNS1', 'ITGA10', 'ITGA11', 'ITGA8', 'RHO', 'ITGB8', 'CAPN1', 'RAC1', 'HRAS']",0.9999956133475378,0,0,15
572,Signal Transduction of S1P Receptor WP26,0.9931430728430265,0.25856911794030973,0.0017790961678907308,"['S1PR2', 'MAPK3']",0.9999956133475378,0,0,2
573,Thermogenesis WP4321,0.9939634939115368,0.5407306478473023,0.003274015627638335,"['KLB', 'UCP1', 'ACSL5', 'CPT1B', 'ACTB', 'ACTG1', 'ADCY10', 'CREB3', 'CPT2', 'CREB3L1', 'CREB3L2', 'DPF3', 'KRAS', 'PLIN1', 'HRAS', 'PRKG1']",0.9999956133475378,0,0,16
574,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9940134514312668,0.17781432748538012,0.0010676932046356886,['CPT2'],0.9999956133475378,0,0,1
575,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9955701836096859,0.1673403279440431,0.0007429336749698881,['MAP1LC3A'],0.9999956133475378,0,0,1
576,Disruption of postsynaptic signaling by CNV WP4875,0.9962425129655011,0.2843003412969283,0.001070266864864502,"['ARC', 'YWHAG', 'MAPK3']",0.9999956133475378,0,0,3
577,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.9967220076022969,0.15803010612952134,0.0005188723817423434,['BCL2'],0.9999956133475378,0,0,1
578,Ciliopathies WP4803,0.9970972562703969,0.598807569342435,0.0017407125624215444,"['DNAH6', 'PKD1L1', 'GLI2', 'PKHD1', 'SUFU', 'HYDIN', 'CNGA1', 'BBS9', 'NEK2', 'ZNF423', 'CEP290', 'DNAI1', 'DNAH11', 'RSPH4A', 'IFT140', 'CCDC114', 'WDR19', 'DCDC2', 'CFAP410', 'RP1L1', 'TMEM17', 'EVC', 'MAK', 'NME9', 'CCDC65', 'CCNQ', 'CCDC151', 'KIZ', 'CFAP53', 'CCNO']",0.9999956133475378,0,0,30
579,Splicing factor NOVA regulated synaptic proteins WP4148,0.9974879582359532,0.30724213606437456,0.0007727761072819976,"['PLCB4', 'CAV2', 'APLP2', 'NCDN']",0.9999956133475378,0,0,4
580,Hippo-Yap signaling pathway WP4537,0.9975742186392461,0.14969990766389657,0.0003635804075102453,['MAP4K1'],0.9999956133475378,0,0,1
581,Glycerolipids and Glycerophospholipids WP4722,0.9982047353131376,0.1422027290448343,0.00025552097040693896,['CDIPT'],0.9999956133475378,0,0,1
582,Wnt Signaling Pathway WP363,0.9983670693472905,0.3228381374722838,0.0005276031775747027,"['GSK3A', 'FRAT1', 'MYC', 'ROR1', 'RAC1']",0.9999956133475378,0,0,5
583,Insulin Signaling WP481,0.9986409378143858,0.5492381060951512,0.0007469564360659194,"['ARF1', 'GSK3A', 'SHC3', 'SLC2A1', 'ELK1', 'FOXO1', 'GYS2', 'GYS1', 'RPS6KA5', 'RAC1', 'GYG1', 'HRAS', 'MAPK3', 'MAP4K1', 'EGR1', 'XBP1', 'JUN', 'PRKCD', 'GAB1', 'PRKCQ', 'SGK1', 'MAP3K14', 'SGK2', 'PFKM', 'ARF6']",0.9999956133475378,0,0,25
584,Interferon type I signaling pathways WP585,0.9986941893808934,0.3156368563685637,0.0004124312960532869,"['ZAP70', 'RPS6KA5', 'RACK1', 'PTPN6', 'RAC1']",0.9999956133475378,0,0,5
585,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.999390824671985,0.2642350419353192,0.00016101451636022423,"['ARC', 'KRAS', 'HRAS', 'MAPK3']",0.9999956133475378,0,0,4
586,Rett syndrome causing genes WP4312,0.9995207891478222,0.2582075325308683,0.00012376550895942137,"['SRRM3', 'EIF2B2', 'IMPDH2', 'GABRD']",0.9999956133475378,0,0,4
587,Glycerophospholipid Biosynthetic Pathway WP2533,0.9997800119209254,0.10527218251389792,2.3161172895611403e-05,['CDIPT'],0.9999956133475378,0,0,1
588,Energy Metabolism WP1541,0.9998169228424689,0.20286271505189107,3.714292935545463e-05,"['PPP3R2', 'MEF2D', 'FOXO1']",0.9999956133475378,0,0,3
589,Fragile X Syndrome  WP4549,0.999927746671921,0.3888497466940822,2.809670337372261e-05,"['GRIA1', 'GABRA1', 'DUSP3', 'CDKN2A', 'GAB1', 'AKAP5', 'DNM2', 'GRIP1', 'ARC', 'PRKAR1A', 'CLTCL1', 'KRAS', 'GABRD', 'AP2M1']",0.9999956133475378,0,0,14
590,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9999694312754579,0.3705192844105022,1.1326475061511338e-05,"['MAP4K1', 'GSK3A', 'SHC3', 'SLC2A1', 'LPL', 'CYP3A4', 'FOXO1', 'GYS1', 'RPS6KA5', 'FASN', 'MAP3K14', 'HRAS', 'FBP1', 'MAPK3']",0.9999956133475378,0,0,14
591,mRNA Processing WP411,0.9999945815309894,0.2977612612033382,1.6134145375059923e-06,"['SF3B5', 'LSM7', 'SF3A1', 'HNRNPK', 'NCBP2', 'CD2BP2', 'SRSF3', 'CSTF2T', 'SNRPE', 'SNU13', 'SRSF9', 'LSM2']",0.9999956133475378,0,0,12
592,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999956133475378,0.20852020240939098,9.14707665563612e-07,"['TMEM17', 'EVC', 'IFT140', 'WDR19', 'CDK20', 'BBS9', 'DYNLL1']",0.9999956133475378,0,0,7
